Genetic association study of TERT gene variants with chronic kidney disease susceptibility in the Chinese population

The incidence and mortality of chronic kidney disease (CKD) are increasing globally. Studies have demonstrated the significance of genetic risk factors in the progression of CKD. Telomerase reverse transcriptase (TERT) may be implicated in the development of CKD. This study aimed to investigate the correlation between TERT gene variants and susceptibility to CKD in the Chinese population. A total of 507 patients with CKD and 510 healthy controls were recruited for this case-control study. Four candidate loci were identified using the MassARRAY platform. Logistic regression analysis was employed to assess the association between TERT gene variants and the risk of CKD. The false positive reporting probability (FPRP) method was utilized to evaluate the validity of statistically significant associations. The multifactorial dimensionality reduction (MDR) method was used to evaluate the interaction between SNPs and the risk of CKD. Furthermore, discrepancies in the clinical features of subjects with diverse genotypes were evaluated using one-way analysis of variance (ANOVA). Our findings revealed a correlation between rs2735940 and rs4635969 and an increased risk of CKD. Stratification analysis indicated that rs4635969 was related to an increased risk of CKD in different subgroups (age ≤ 50 years and male). MDR analysis indicated that the two-site model (rs2735940 and rs4635969) was the best prediction model. Furthermore, the rs2735940 GG genotype was found to be linked to an increased level of microalbuminuria (MAU) in patients with CKD. Our study is the first to reveal a connection between TERT gene variants and susceptibility to CKD, providing new insights into the field of nephrology.

Escherichia coli and HPV16 coinfection may contribute to the development of cervical cancer

Persistent human papillomavirus HPV infection is a necessary but insufficient condition for cervical cancer. Microorganisms are crucial environmental factors in cancers susceptibility and progression, recently attracting considerable attention. This study aimed to determine the infection status and relationship between high-risk HPV (HR-HPV) and lower genital tract infectious pathogens in cervical cancer and its precursors. From a retrospective and a prospective cohort analysis, Escherichia coli (E. coli) dominated the pathogens isolated from cervical discharges, and an isolation rate uptrend has been shown recently. HPV16 and E. coli's coinfection rate gradually increased with the severity of cervical intraepithelial neoplasia. The adhesion and invasion abilities of the isolated E. coli to HPV16-positive SiHa cells were evaluated in vitro. The TCGA database and cervical tissues samples analysis showed that IL-10 was upregulated in cervical cancer. IL-10 expression levels increased in tissue samples with the severity of cervical cancer and its precursors with HPV16 and E. coli coinfection. Although no significant changes in IL-10 production were observed in the co-culture supernatant, we hypothesized that Treg immune cells in the tumour microenvironment might be responsible for the local IL-10 upregulation, according to our data showing Foxp3 upregulation and an upward trend with the cervical intraepithelial neoplasia grading to cancer and tumours with E. coli and HPV16 coinfection. Our data provide insights into the possible role of E. coli in cervical cancer progression and suggest that the application of HPV and E. coli screening programs may be an effective strategy to relieve the burden of cervical cancer and its precursor lesions.

Multi-omics reveals the switch role of abnormal methylation in the regulation of decidual macrophages function in recurrent spontaneous abortion

RSA, recurrent spontaneous abortion, often causes serious physical damage and psychological pressure in reproductive women with unclarified pathogenesis. Abnormal function of decidual cells and aberrant DNA methylation have been reported to cause RSA, but their association remains unclear. Here, we integrated transcriptome, DNA methylome, and scRNA-seq to clarify the regulatory relationship between DNA methylation and decidual cells in RSA. We found that DNA methylation mainly influenced the function of decidual macrophages (DMs), of which four hub genes, HLA-A, HLA-F, SQSTM1/P62, and Interferon regulatory factor 7 (IRF7), related to 22 hypomethylated CpG sites, regulated 16 hub pathways to participate in RSA pathogenesis. In particular, using transcription factor analysis, it is suggested that the upregulation of IRF7 transcription was associated with enhanced recruitment of the transcription factor STAT1 by the hypomethylated promoter region of IRF7. As the current research on DNA methylation of macrophages in the uterine microenvironment of RSA is still blank, our systematic picture of abnormal DNA methylation in regulating DM function provides new insights into the role of DNA methylation in RSA occurrence, which may aid in further prevention and treatment of RSA.

An Exploratory Content Analysis of the Use of Health Communication Strategies and Presence of Objectification in Fitness Influencer Social Media Posts

Health and fitness content intended to inspire people to live healthy lives (e.g. "fitspiration") has been linked to negative body image among girls and young women. Fitness influencers purport wanting to motivate healthy behaviors. This study seeks to examine the presence of strategies known to positively influence health behaviors (e.g. attitudes, self-efficacy) as well as of content known to have a negative influence (e.g. objectification) among fitness influencers. We conducted a content analysis (N = 441) of a random sample of one year of posts from four Instagram fitness influencers popular with girls and young women in the United States. The main analysis consisted of codes related to objectification, health promotion strategies, health-related content, and social engagement (i.e., likes). We found that fitness influencers included content that conveyed constructs previously found to positively influence health behaviors (e.g., attitudes and self-efficacy), but objectification was frequently present, in more than half of the posts. Additionally, we found that the presence of objectification in posts was negatively associated with likes, a form of social endorsement. We suggest health communicators aim to work in tandem with fitness influencers to include content that may motivate positive health behaviors and improve media literacy and that influencers aim to reduce the amount of objectifying content included in their posts. Our findings shed light on content being conveyed and possible insights into the negative effects associated with viewing such content.

Clinical Presentation, Management, and Diagnostic Performance of 2021 Criteria for Paraneoplastic Neurologic Syndromes in Childhood

BACKGROUND AND OBJECTIVES

Paraneoplastic neurologic syndromes (PNSs) are remote neurologic immune-related effects of tumors. The clinical characteristics of pediatric PNSs remain unclear. We retrospectively examined the clinical characteristics of cases of pediatric PNSs and assessed the performance of the 2021 diagnostic criteria in children.

METHODS

Patients hospitalized in the Beijing Children's Hospital between June 2015 and June 2023 and fulfilling the description of definite by 2004 diagnostic criteria of PNSs were included. A retrospective analysis of clinical characteristics was conducted, and the 2021 diagnostic criteria were applied to rediagnostic stratification.

RESULTS

Among the 42 patients included, the most common neurologic syndrome was opsoclonus-myoclonus syndrome (OMS) (62%), followed by rapidly progressive cerebellar syndrome (26%). Most tumors were neuroblastomas (88%), with few being ovarian teratomas (10%). Approximately 71% (30/42) of patients were classified as definite and 24% (10/42) as probable according to the 2021 criteria. All cases judged as probable exhibited rapidly progressive cerebellar ataxia with neuroblastoma. For OMS, chemotherapy was administered based on the tumor's risk stage, accompanied by regular infusion of IV gamma globulin and oral steroids following tumor diagnosis. Twenty-one patients underwent regular follow-ups over 4.92 (0.58-7.58) years. The initial hospitalization recorded a median score of 12 (7-14) on the Mitchell and Pike OMS rating scale, decreasing to 0 (0-5) at the final follow-up. In cases of rapidly progressive cerebellar syndrome, a similar therapeutic regimen was used. Nine patients underwent regular follow-ups over 4.42 (1.17-7.50) years. The mean modified Rankin scale score at first hospitalization was 4 (3-4), reducing to 1 (0-4) at the final follow-up. Only 17% (5/30) of patients across both groups exhibited poor response to this regimen. Among these 5 patients, 4 belonged to the low-risk group (without chemotherapy).

DISCUSSION

OMS followed by rapidly progressive cerebellar ataxia are the most common forms of PNSs in children and are associated with neuroblastoma. An aggressive approach with multiple immunotherapies may improve the prognosis of neuroblastoma-associated PNSs. The 2021 criteria perform well in pediatric PNSs. However, we propose upgrading the classification of antibody-negative rapidly progressive cerebellar ataxia with neuroblastoma to definite diagnosis. This adjustment aims to further improve the diagnostic efficacy of this diagnostic criterion in childhood.

Iridium(III)-Based PD-L1 Agonist Regulates p62 and ATF3 for Enhanced Cancer Immunotherapy

Anti-PD-L1 immunotherapy, a new lung cancer treatment, is limited to a few patients due to low PD-L1 expression and tumor immunosuppression. To address these challenges, the upregulation of PD-L1 has the potential to elevate the response rate and efficiency of anti-PD-L1 and alleviate the immunosuppression of the tumor microenvironment. Herein, we developed a novel usnic acid-derived Iridium(III) complex, Ir-UA, that boosts PD-L1 expression and converts "cold tumors" to "hot". Subsequently, we administered Ir-UA combined with anti-PD-L1 in mice, which effectively inhibited tumor growth and promoted CD4+ and CD8+ T cell infiltration. To our knowledge, Ir-UA is the first iridium-based complex to stimulate the expression of PD-L1 by explicitly regulating its transcription factors, which not only provides a promising platform for immune checkpoint blockade but, more importantly, provides an effective treatment strategy for patients with low PD-L1 expression.

Impact of sarcopenia in elderly patients undergoing elective total hip arthroplasty on postoperative outcomes: a propensity score-matched study

OBJECTIVE

Frailty poses a crucial risk for postoperative complications in the elderly, with sarcopenia being a key component. The impact of sarcopenia on postoperative outcomes after total hip arthroplasty (THA) is still unclear. This study investigated the potential link between sarcopenia and postoperative outcomes among elderly THA patients.

METHODS

Totally 198 older patients were enrolled in this study. Sarcopenia in this group was determined by assessing the skeletal muscle index, which was measured using computed tomography at the 12th thoracic vertebra and analyzed semi-automatically with MATLAB R2020a. Propensity score matching (PSM) was employed to evaluate postoperative complications of grade II and above (POCIIs).

RESULTS

The variables balanced using PSM contained age, sex and comorbidities including hypertension, diabetes, hyperlipidemia and COPD. Before PSM, sarcopenic patients with reduced BMI (24.02 ± 0.24 vs. 27.11 ± 0.66, P < 0.001) showed higher POCIIs rates (48.31% vs. 15%, P = 0.009) and more walking-assisted discharge instances (85.96% vs. 60%, P = 0.017) compared with non-sarcopenia patients. After PSM, this group maintained reduced BMI (23.47 ± 0.85 vs. 27.11 ± 0.66, P = 0.002), with increased POCIIs rates (54.41% vs. 15%, P = 0.002) and heightened reliance on walking assistance at discharge (86.96% vs. 60%, P = 0.008).

CONCLUSION

Sarcopenia patients exhibited a higher incidence of POCIIs and poorer physical function at discharge. Sarcopenia could serve as a valuable prognostic indicator for elderly patients undergoing elective THA.

Deciphering the importance of culture pH on CD22 CAR T-cells characteristics

BACKGROUND

Chimeric antigen receptor (CAR) T-cells have demonstrated significant efficacy in targeting hematological malignancies, and their use continues to expand. Despite substantial efforts spent on the optimization of protocols for CAR T-cell manufacturing, critical parameters of cell culture such as pH or oxygenation are rarely actively monitored during cGMP CAR T-cell generation. A comprehensive understanding of the role that these factors play in manufacturing may help in optimizing patient-specific CAR T-cell therapy with maximum benefits and minimal toxicity.

METHODS

This retrospective study examined cell culture supernatants from the manufacture of CAR T-cells for 20 patients with B-cell malignancies enrolled in a phase 1/2 clinical trial of anti-CD22 CAR T-cells. MetaFLEX was used to measure supernatant pH, oxygenation, and metabolites, and a Bio-Plex assay was used to assess protein levels. Correlations were assessed between the pH of cell culture media throughout manufacturing and cell proliferation as well as clinical outcomes. Next-generation sequencing was conducted to examine gene expression profiles of the final CAR T-cell products.

RESULTS

A pH level at the lower range of normal at the beginning of the manufacturing process significantly correlated with measures of T-cell expansion and metabolism. Stable or rising pH during the manufacturing process was associated with clinical response, whereas a drop in pH was associated with non-response.

CONCLUSIONS

pH has potential to serve as an informative factor in predicting CAR T-cell quality and clinical outcomes. Thus, its active monitoring during manufacturing may ensure a more effective CAR T-cell product.

Unraveling the mechanism of norfloxacin removal and fate of antibiotics resistance genes (ARGs) in the sulfur-mediated autotrophic denitrification via metagenomic and metatranscriptomic analyses

The co-contamination of antibiotics and nitrogen has attracted widespread concerns due to its potential harm to ecological safety and human health. Sulfur-driven autotrophic denitrification (SAD) with low sludge production rate was adopted to treat antibiotics laden-organic deficient wastewater. Herein, a lab-scale sequencing batch reactor (SBR) was established to explore the simultaneous removal of nitrate and antibiotics, i.e. Norfloxacin (NOR), as well as microbial response mechanism of SAD sludge system towards NOR exposure. About 80.78 % of NOR was removed by SAD sludge when the influent NOR level was 0.5 mg/L, in which biodegradation was dominant removal route. The nitrate removal efficiency decreased slightly from 98.37 ± 0.58 % to 96.58 ± 1.03 % in the presence of NOR. Thiobacillus and Sulfurimonas were the most abundant sulfur-oxidizing bacteria (SOB) in SAD system, but Thiobacillus was more sensitive to NOR. The up-regulated genes related to Xenobiotics biodegradation and metabolism and CYP450 indicated the occurrence of NOR biotransformation in SAD system. The resistance of SAD sludge to the exposure of NOR was mainly ascribed to antibiotic efflux. And the effect of antibiotic inactivation was enhanced after long-term fed with NOR. The NOR exposure resulted in the increased level of antibiotics resistance genes (ARGs) and mobile genetic elements (MGEs). Besides, the enhanced ARG-MGE co-existence patterns further reveals the higher horizontal mobility potential of ARGs under NOR exposure pressures. The most enriched sulfur oxidizing bacterium Thiobacillus was a potential host for most of ARGs. This study provides a new insight for the treatment of NOR-laden wastewater with low C/N ratio based on the sulfur-mediated biological process.

Promoting CO2 Electroreduction to Ethane by Iodide-Derived Copper with the Hydrophobic Surface

Electrochemical reduction of CO2 to value-added products provides a feasible pathway for mitigating net carbon emissions and storing renewable energy. However, the low dimerization efficiency of the absorbed CO intermediate (*CO) and the competitive hydrogen evolution reaction hinder the selective electroreduction of CO2 to ethane (C2H6) with a high energy density. Here, we designed hydrophobic iodide-derived copper electrodes (I-Cu/Nafion) for reducing CO2 to C2H6. The Faradaic efficiency of C2H6 reached 23.37% at -0.7 V vs RHE over the I-Cu/Nafion electrode in an H-type cell, which was about 1.7 times higher than that of the I-Cu electrode. The hydrophobic properties of the I-Cu/Nafion electrodes led to an increase in the local CO2 concentration and stabilized the Cu+ species. In situ Raman characterizations and density functional theory calculations indicate that the enhanced performances could be ascribed to the strong *CO adsorption and decreased the formation energy of *COOH and *COCOH intermediates. This study highlights the effect of the hydrophobic surface on Cu-based catalysts in the electroreduction of CO2 and provides a promising way to adjust the selectivity of C2 products.

Combined Transcranial Doppler and Melatonin Levels to Predict Delayed Cerebral Ischemia After Subarachnoid Hemorrhage

OBJECTIVE

To investigate the early prediction value of transcranial Doppler ultrasound (TCD) combined with serum melatonin level for delayed cerebral ischemia (DCI) caused by subarachnoid hemorrhage (SAH).

METHODS

This paper is a prospective study. A total of 120 patients with SAH treated were included. The patients were divided into the DCI group (40 cases) and non-DCI group (80 cases) according to whether DCI occurred 14 days after SAH (DCI usually occurs 4 to 14 d after bleeding). Baseline data, serum melatonin level, and TCD test results within 24 hours after admission were compared between the 2 groups. Multivariate logistic analysis was used to analyze the factors affecting the occurrence of DCI after SAH. The value of serum melatonin level, middle cerebral artery mean blood flow velocity (MBFV) and their combination in predicting DCI in SAH patients was evaluated.

RESULTS

Univariate analysis showed that there were statistically significant differences in the proportion of Fisher grade, Hunt-Hess grade, serum melatonin level, middle cerebral artery systolic blood flow velocity (Vs), MBFV and pulse index (PI) between the 2 groups (P<0.05). Serum melatonin levels, middle cerebral artery Vs, MBFV, and PI in the DCI group were higher than those in non-DCI group. Logistic regression (LR) analysis showed that serum melatonin level (OR=1.796, 95% CI: 1.575-4.123) and middle cerebral artery MBFV (OR=3.279, 95% CI: 2.112-4.720] were the influencing factors for DCI in SAH patients (P<0.05).

CONCLUSION

Middle cerebral artery MBFV and serum melatonin levels were higher in patients with SAH complicated with DCI, and the combination of the 2 could provide a reference for early clinical prediction of DCI in patients with aneurysmal subarachnoid hemorrhage (aSAH).

Graphene Quantum Dots Eradicate Resistant and Metastatic Cancer Cells by Enhanced Interfacial Inhibition

Drug-resistant and metastatic cancer cells such as a small population of cancer stem cells (CSCs) play a crucial role in metastasis and relapse. Conventional small-molecule chemotherapeutics, however, are unable to eradicate drug-resistant CSCs owing to limited interface inhibitory effects. Herein, it is reported that enhanced interfacial inhibition leading to eradication of drug-resistant CSCs can be dramatically induced by self-insertion of bioactive graphene quantum dots (GQDs) into DNA major groove (MAG) sites in cancer cells. Since transcription factors regulate gene expression at the MAG site, MAG-targeted GQDs exert greatly enhanced interfacial inhibition, downregulating the expression of a collection of cancer stem genes such as ALDH1, Notch1, and Bmi1. Moreover, the nanoscale interface inhibition mechanism reverses cancer multidrug resistance (MDR) by inhibiting MDR1 gene expression when GQDs are used at a nontoxic concentration (1/4 × half-maximal inhibitory concentration (IC50)) as the MDR reverser. Given their high efficacy in interfacial inhibition, CSC-mediated migration, invasion, and metastasis of cancer cells can be substantially blocked by MAG-targeted GQDs, which can also be harnessed to sensitize clinical cytotoxic agents for improved efficacy in combination chemotherapy. These findings elucidate the inhibitory effects of the enhanced nano-bio interface at the MAG site on eradicating CSCs, thus preventing cancer metastasis and recurrence.

Diffusion-rate sieving of propylene and propane mixtures in a cooperatively dynamic porous crystal

Selective molecular recognition is an important alternative to the energy-intensive industrial separation process. Porous coordination polymers (PCPs) offer designing platforms for gas separation because they possess precise controllability over structures at the molecular level. However, PCPs-based gas separations are dominantly achieved using strong adsorptive sites for thermodynamic recognition or pore-aperture control for size sieving, which suffer from insufficient selectivity or sluggish kinetics. Developing PCPs that work at high temperatures and feature both high uptake capacity and selectivity is urgently required but remains challenging. Herein, we report diffusion-rate sieving of propylene/propane (C3H6/C3H8) at 300 K by constructing a PCP material whose global and local dynamics cooperatively govern the adsorption process via the mechanisms of the gate opening for C3H6 and the diffusion regulation for C3H8, respectively, yielding substantial differences in both uptake capacity and adsorption kinetics. Dynamic separation of an equimolar C3H6/C3H8 mixture reveals outstanding sieving performance with a C3H6 purity of 99.7% and a separation factor of 318.

Two-dimensional fullerene-based monolayer materials assembled by C80 and Sc3N@C80

Construction of two-dimensional (2D) materials using fullerenes as building blocks has attracted particular attention, primarily due to their ability to integrate desired functionalities into devices. However, realization of stable 2D phases of polymerized fullerenes remains a big challenge. Here, we propose two stable 2D monolayer phases with covalently bridged C80 cages, namely α-C80-2D and β-C80-2D, which are semiconductors with strong absorption in the long wave range and appreciable carrier mobility, respectively. The high stability originates from the bond energy released by the [2+2] cycloaddition polymerization of C80 is greater than the deformation energy of a cage. Starting from α-C80-2D, endohedral incorporation of the Sc3N molecule into each C80 cage leads to 2D semiconductors of α-Sc3N@C80-2D and α'-Sc3N@C80-2D, which possess exceptional stability and diverse physical properties, including unique electronic band structures, strong optical absorption in the visible (VIS) to near-infrared (NIR) regime, and anisotropic optical characteristics. Remarkably, a temperature-induced order-disorder transition in the α-Sc3N@C80-2D phase has been observed at elevated temperatures above 600 K. These findings expand the family of 2D carbon materials and provide useful clue for the potential applications of fullerene-assembled monolayer networks.

Dual inhibition of oxidative phosphorylation and glycolysis to enhance cancer therapy

Dual suppression of oxidative phosphorylation (OXPHOS) and glycolysis can disrupt metabolic adaption of cancer cells, inhibiting energy supply and leading to successful cancer therapy. Herein, we have developed an α-tocopheryl succinate (α-TOS)-functionalized iridium(III) complex Ir2, a highly lipophilic mitochondria targeting anticancer molecule, could inhibit both oxidative phosphorylation (OXPHOS) and glycolysis, resulting in the energy blockage and cancer growth suppression. Mechanistic studies reveal that complex Ir2 induces reactive oxygen species (ROS) elevation and mitochondrial depolarization, and triggers DNA oxidative damage. These damages could evoke the cancer cell death with the mitochondrial-relevant apoptosis and autophagy. 3D tumor spheroids experiment demonstrates that Ir2 owned superior antiproliferation performance, as the potent anticancer agent in vivo. This study not only provided a new path for dual inhibition of both mitochondrial OXPHOS and glycolytic metabolisms with a novel α-TOS-functionalized metallodrug, but also further demonstrated that the mitochondrial-relevant therapy could be effective in enhancing the anticancer performance.

Treatment of nasolabial fold rhabdomyosarcoma in children: A single-institution experience

OBJECTIVES

To summarize the clinical characteristics and prognosis of children with nasolabial fold rhabdomyosarcoma (RMS).

METHODS

Retrospective review of children treated for nasolabial fold RMS from January 2014 to September 2019.

RESULTS

Of 21 patients with nasolabial fold RMS, 90.48% were alveolar subtype, in which PAX3/7-FOXO1 fusion positive accounted for 87.5%. Ten patients (47.62%) had nodals invasion. Almost all patients received comprehensive treatment (chemotherapy [100%], radiation therapy [100%], and surgery [95.24%]). The median follow-up time was 34.3 months. The 3-year overall survival (OS) and event-free survival (EFS) was 67.7% ± 14.1% and 42.1% ± 13.5%, respectively. Four patients had regional lymph node relapse (NR), all in the ipsilateral submandibular lymph node region.

CONCLUSION

Majority of the patients with RMS in the nasolabial fold area were alveolar subtype and had positive PAX3/7-FOXO1 gene fusion. In addition, the nasolabial fold RMS had a high probability of regional lymph node metastasis in the submandibular area. To maintain the facial aesthetics and functions, the surgical area for nasolabial fold RMS is often very conservative and restricted. This could be one of the contributors for the poor prognosis of nasolabial fold RMS beside its worse pathological subtype and gene fusion.

Amplitude Analysis of the B^{0}→K^{*0}μ^{+}μ^{-} Decay

An amplitude analysis of the B^{0}→K^{*0}μ^{+}μ^{-} decay is presented using a dataset corresponding to an integrated luminosity of 4.7  fb^{-1} of pp collision data collected with the LHCb experiment. For the first time, the coefficients associated to short-distance physics effects, sensitive to processes beyond the standard model, are extracted directly from the data through a q^{2}-unbinned amplitude analysis, where q^{2} is the μ^{+}μ^{-} invariant mass squared. Long-distance contributions, which originate from nonfactorizable QCD processes, are systematically investigated, and the most accurate assessment to date of their impact on the physical observables is obtained. The pattern of measured corrections to the short-distance couplings is found to be consistent with previous analyses of b- to s-quark transitions, with the largest discrepancy from the standard model predictions found to be at the level of 1.8 standard deviations. The global significance of the observed differences in the decay is 1.4 standard deviations.

Measurements of All-Particle Energy Spectrum and Mean Logarithmic Mass of Cosmic Rays from 0.3 to 30 PeV with LHAASO-KM2A

We present the measurements of all-particle energy spectrum and mean logarithmic mass of cosmic rays in the energy range of 0.3-30 PeV using data collected from LHAASO-KM2A between September 2021 and December 2022, which is based on a nearly composition-independent energy reconstruction method, achieving unprecedented accuracy. Our analysis reveals the position of the knee at 3.67±0.05±0.15  PeV. Below the knee, the spectral index is found to be -2.7413±0.0004±0.0050, while above the knee, it is -3.128±0.005±0.027, with the sharpness of the transition measured with a statistical error of 2%. The mean logarithmic mass of cosmic rays is almost heavier than helium in the whole measured energy range. It decreases from 1.7 at 0.3 PeV to 1.3 at 3 PeV, representing a 24% decline following a power law with an index of -0.1200±0.0003±0.0341. This is equivalent to an increase in abundance of light components. Above the knee, the mean logarithmic mass exhibits a power law trend towards heavier components, which is reversal to the behavior observed in the all-particle energy spectrum. Additionally, the knee position and the change in power-law index are approximately the same. These findings suggest that the knee observed in the all-particle spectrum corresponds to the knee of the light component, rather than the medium-heavy components.

Impact of the COVID-19 pandemic on the demographic and disease burden of pediatric malignant solid tumors in China: a single-center, cross-sectional study

Background

With the development of the novel coronavirus disease 2019 (COVID-19), China implemented measures in an attempt to control the infection rate. We conducted a single-center, cross-sectional study to ascertain the impact of the COVID-19 pandemic on the equitable availability of medical resources for children diagnosed with malignant solid tumors in China.

Methods

Data on the demographics, clinical characteristics, and medical expenses of 876 patients diagnosed with neuroblastoma, rhabdomyosarcoma (RMS), Wilms tumor, hepatoblastoma (HB), Ewing sarcoma (ES), and central nervous system (CNS) tumors from 2019 to 2021, during the COVID-19 pandemic, were retrospectively collected from the National Center for Children's Health. The Pearson χ2 test and Mann-Whitney test were performed to analyze the differences among variables.

Results

Except for the regional origin of children with tumors during the epidemic, no significant differences were found in the demographic or clinical characteristics of patients at initial diagnosis. The number of patients from northern China and northeastern China who attended Beijing Children's Hospital (BCH) increased after the outbreak of COVID-19 (P=0.001). There was no significant alteration observed in the frequency of hospitalizations per individual per annum (P=0.641) or the mean expense incurred per individual per hospitalization (P=0.361). In addition, the medical insurance coverage rate of real-time settlement increased year by year.

Conclusions

After the COVID-19 outbreak, the origin of patients with solid tumor who visited BCH was concentrated in the northern region of China. COVID-19 had no impact on the other demographic factors, clinical characteristics, or economic burden of patients with pediatric malignant solid tumors.

Structures and bonding characteristics of KCl(H2O)n clusters with n = 1-10 based on density functional theory

Aqueous inorganic salt solutions play a prominent role in both physiological and chemical experiments, and significant attention has been directed toward understanding the mechanisms underlying salt dissolution. In our effort to elucidate the hydration process of potassium chloride, we employed a comprehensive genetic algorithm to explore the structures of KCl(H2O)n (n = 1-10). A series of stable structures were identified by high-level ab initio optimization and single-point energy calculations with a zero-point energy correction. An analysis of the probability distribution of KCl(H2O)1-10 revealed that clusters with high probability at low temperatures exhibit reduced probabilities at higher temperatures, while others become more prevalent. When n = 1-9, the contact ion pair configurations or partially dissociated structures dominate in the system, and the probability distribution plot shows that the proportion of the solvent-separated ion pair (SSIP) structures of KCl(H2O)n is very small, while the SSIP configuration in KCl(H2O)10 becomes a stable structure with increasing temperature. The results from natural bond orbital analysis reveal a stronger interaction between chloride ions and water molecules. These findings provide valuable insights for a more comprehensive understanding of the intricacies of potassium chloride dissolution in water.

Consolidating Organometallic Complex Empowers Mitochondria-Directed Chemotherapy against Resistant Cancer via Stemness and Metastasis Inhibition

Cancer treatment has faced severe obstacles due to the smart biological system of cancer cells. Herein, we report a three-in-one agent Ir-CA via attenuation of cancer cell stemness with the down-regulated biomarker CD133 expression from the mitochondria-directed chemotherapy. Over 80% of Ir-CA could accumulate in mitochondria, result in severe mitochondrial dysfunctions, and subsequently initiate mitophagy and cell cycle arrest to kill cisplatin-resistant A549R cells. In vitro and in vivo antimetastatic experiments demonstrated that Ir-CA can effectively inhibit metastasis with down-regulated MMP-2/MMP-9. RNA seq analysis and Western blotting indicated that Ir-CA also suppresses the GSTP1 expression to decrease the intracellular Pt-GS adducts, resulting in the detoxification and resensitization to cisplatin of A549R cells. In vivo evaluation indicated that Ir-CA restrains the tumor growth and has minimal side effects and superior biocompatibility. This work not only provides the first three-in-one agent to attenuate cancer cell stemness and simultaneously realize anticancer, antimetastasis, and conquer metallodrug resistance but also demonstrates the effectiveness of the mitochondria-directed strategy in cancer treatment.

Peptide derived from RAGE efficiently improves oocyte development through attenuating oxidative stress in oocytes of mice with polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) is a common and complex endocrine disorder in reproductive-aged women that frequently leads to infertility due to poor oocyte quality. In this study, we identified a new active peptide (advanced glycation end products receptors RAGE344-355 ) from PCOS follicular fluid using mass spectrometry. We found that supplementing PCOS-like mouse oocytes with RAGE344-355 attenuated both meiotic defects and oxidative stress levels, ultimately preventing developmental defects. Additionally, our results suggest that RAGE344-355 may interact with eEF1a1 to mitigate oxidative meiotic defects in PCOS-like mouse oocytes. These findings highlight the potential for further clinical development of RAGE344-355 as a potent supplement and therapeutic option for women with PCOS. This research addresses an important clinical problem and offers promising opportunities for improving oocyte quality in PCOS patients.

Accuracy of quantitative viral secondary standards: a re-examination

Interlaboratory agreement of viral load assays depends on the accuracy and uniformity of quantitative calibrators. Previous work demonstrated poor agreement of secondary cytomegalovirus (CMV) standards with nominal values. This study re-evaluated this issue among commercially produced secondary standards for both BK virus (BKV) and CMV, using digital polymerase chain reaction (dPCR) to compare the materials from three different manufacturers. Overall, standards showed an improved agreement compared to prior work, against nominal values in both log10 copies/mL and log10 international unit (IU)/mL, with bias from manufacturer-assigned nominal values of 0.0-0.9 log10 units (either copies or IU)/mL. Standards normalized to IU and those values assigned by dPCR rather than by real-time PCR (qPCR) showed better agreement with nominal values. The latter reinforces prior conclusions regarding the utility of using such methods for quantitative value assignment in reference materials. Quantitative standards have improved over the last several years, and the remaining bias from nominal values might be further reduced by universal implementation of dPCR methods for value assignment, normalized to IU.

IMPORTANCE

Interlaboratory agreement of viral load assays depends on accuracy and uniformity of quantitative calibrators. Previous work, published in JCM several years ago, demonstrated poor agreement of secondary cytomegalovirus (CMV) standards with nominal values. This study re-evaluated this issue among commercially produced secondary standards for both BK virus (BKV) and CMV, using digital polymerase chain reaction (dPCR) to compare the materials from three different manufacturers. Overall, standards showed an improved agreement compared to prior work, against nominal values, indicating a substantial improvement in the production of accurate secondary viral standards, while supporting the need for further work in this area and for the broad adaption of international unit (IU) as a reporting standard for quantitative viral load results.

Functional Upgrading of an Organo-Ir(III) Complex to an Organo-Ir(III) Prodrug as a DNA Damage-Responsive Autophagic Inducer for Hypoxic Lung Cancer Therapy

The efficiency of nitrogen mustards (NMs), among the first chemotherapeutic agents against cancer, is limited by their monotonous mechanism of action (MoA). And tumor hypoxia is a significant obstacle in the attenuation of the chemotherapeutic efficacy. To repurpose the drug and combat hypoxia, herein, we constructed an organo-Ir(III) prodrug, IrCpNM, with the composition of a reactive oxygen species (ROS)-inducing moiety (Ir-arene fragment)-a hypoxic responsive moiety (azo linker)-a DNA-alkylating moiety (nitrogen mustard), and realized DNA damage response (DDR)-mediated autophagy for hypoxic lung cancer therapy for the first time. Prodrug IrCpNM could upregulate the level of catalase (CAT) to catalyze the decomposition of excessive H2O2 to O2 and downregulate the expression of the hypoxia-inducible factor (HIF-1α) to relieve hypoxia. Subsequently, IrCpNM initiates the quadruple synergetic actions under hypoxia, as simultaneous ROS promotion and glutathione (GSH) depletion to enhance the redox disbalance and severe oxidative and cross-linking DNA damages to trigger the occurrence of DDR-mediated autophagy via the ATM/Chk2 cascade and the PIK3CA/PI3K-AKT1-mTOR-RPS6KB1 signaling pathway. In vitro and in vivo experiments have confirmed the greatly antiproliferative capacity of IrCpNM against the hypoxic solid tumor. This work demonstrated the effectiveness of the DNA damage-responsive organometallic prodrug strategy with the microenvironment targeting system and the rebirth of traditional chemotherapeutic agents with a new anticancer mechanism.

Fraction of χ_{c} Decays in Prompt J/ψ Production Measured in pPb Collisions at sqrt[s_{NN}]=8.16 TeV

The fraction of χ_{c1} and χ_{c2} decays in the prompt J/ψ yield, F_{χ_{c}→J/ψ}=σ_{χ_{c}→J/ψ}/σ_{J/ψ}, is measured by the LHCb detector in pPb collisions at sqrt[s_{NN}]=8.16  TeV. The study covers the forward (1.5 Collapse

Key Words Collapse

MESH Headings Collapse

Grants Collapse

Affiliation(s)

R Aaij Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
A S W Abdelmotteleb Department of Physics, University of Warwick, Coventry, United Kingdom
C Abellan Beteta Physik-Institut, Universität Zürich, Zürich, Switzerland
F Abudinén Department of Physics, University of Warwick, Coventry, United Kingdom
T Ackernley Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
B Adeva Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
M Adinolfi H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
P Adlarson Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
C Agapopoulou European Organization for Nuclear Research (CERN), Geneva, Switzerland
C A Aidala University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
Z Ajaltouni Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
S Akar University of Cincinnati, Cincinnati, Ohio, USA
K Akiba Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
P Albicocco INFN Laboratori Nazionali di Frascati, Frascati, Italy
J Albrecht Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
F Alessio European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Alexander School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A Alfonso Albero ICCUB, Universitat de Barcelona, Barcelona, Spain
Z Aliouche Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
P Alvarez Cartelle Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
R Amalric LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
S Amato Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
J L Amey H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
Y Amhis Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France European Organization for Nuclear Research (CERN), Geneva, Switzerland
L An School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
L Anderlini INFN Sezione di Firenze, Firenze, Italy
M Andersson Physik-Institut, Universität Zürich, Zürich, Switzerland
A Andreianov Affiliated with an institute covered by a cooperation agreement with CERN
P Andreola Physik-Institut, Universität Zürich, Zürich, Switzerland
M Andreotti INFN Sezione di Ferrara, Ferrara, Italy
D Andreou Syracuse University, Syracuse, New York, USA
A A Anelli INFN Sezione di Milano-Bicocca, Milano, Italy
D Ao University of Chinese Academy of Sciences, Beijing, China
F Archilli INFN Sezione di Roma Tor Vergata, Roma, Italy
M Argenton INFN Sezione di Ferrara, Ferrara, Italy
S Arguedas Cuendis Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica
A Artamonov Affiliated with an institute covered by a cooperation agreement with CERN
M Artuso Syracuse University, Syracuse, New York, USA
E Aslanides Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
M Atzeni Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
B Audurier Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
D Bacher Department of Physics, University of Oxford, Oxford, United Kingdom
I Bachiller Perea Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
S Bachmann Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
M Bachmayer Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
J J Back Department of Physics, University of Warwick, Coventry, United Kingdom
A Bailly-Reyre LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
P Baladron Rodriguez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
V Balagura Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
W Baldini INFN Sezione di Ferrara, Ferrara, Italy
J Baptista de Souza Leite Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
M Barbetti INFN Sezione di Firenze, Firenze, Italy
I R Barbosa Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil)
R J Barlow Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
S Barsuk Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
W Barter School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Bartolini Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
F Baryshnikov Affiliated with an institute covered by a cooperation agreement with CERN
J M Basels I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
G Bassi INFN Sezione di Pisa, Pisa, Italy
B Batsukh Institute Of High Energy Physics (IHEP), Beijing, China
A Battig Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
A Bay Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
A Beck Department of Physics, University of Warwick, Coventry, United Kingdom
M Becker Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
F Bedeschi INFN Sezione di Pisa, Pisa, Italy
I B Bediaga Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
A Beiter Syracuse University, Syracuse, New York, USA
S Belin Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
V Bellee Physik-Institut, Universität Zürich, Zürich, Switzerland
K Belous Affiliated with an institute covered by a cooperation agreement with CERN
I Belov INFN Sezione di Genova, Genova, Italy
I Belyaev Affiliated with an institute covered by a cooperation agreement with CERN
G Benane Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
G Bencivenni INFN Laboratori Nazionali di Frascati, Frascati, Italy
E Ben-Haim LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
A Berezhnoy Affiliated with an institute covered by a cooperation agreement with CERN
R Bernet Physik-Institut, Universität Zürich, Zürich, Switzerland
S Bernet Andres DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
H C Bernstein Syracuse University, Syracuse, New York, USA
C Bertella Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
A Bertolin Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
C Betancourt Physik-Institut, Universität Zürich, Zürich, Switzerland
F Betti School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
J Bex Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
Ia Bezshyiko Physik-Institut, Universität Zürich, Zürich, Switzerland
J Bhom Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
M S Bieker Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
N V Biesuz INFN Sezione di Ferrara, Ferrara, Italy
P Billoir LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
A Biolchini Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
M Birch Imperial College London, London, United Kingdom
F C R Bishop Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
A Bitadze Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
A Bizzeti School of Physics and Astronomy, Monash University, Melbourne, Australia Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil Center for High Energy Physics, Tsinghua University, Beijing, China Institute Of High Energy Physics (IHEP), Beijing, China School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China University of Chinese Academy of Sciences, Beijing, China Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany School of Physics, University College Dublin, Dublin, Ireland INFN Sezione di Bari, Bari, Italy INFN Sezione di Bologna, Bologna, Italy INFN Sezione di Ferrara, Ferrara, Italy INFN Sezione di Firenze, Firenze, Italy INFN Laboratori Nazionali di Frascati, Frascati, Italy INFN Sezione di Genova, Genova, Italy INFN Sezione di Milano, Milano, Italy INFN Sezione di Milano-Bicocca, Milano, Italy INFN Sezione di Cagliari, Monserrato, Italy Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy INFN Sezione di Perugia, Perugia, Italy INFN Sezione di Pisa, Pisa, Italy INFN Sezione di Roma La Sapienza, Roma, Italy INFN Sezione di Roma Tor Vergata, Roma, Italy Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland National Center for Nuclear Research (NCBJ), Warsaw, Poland Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania Affiliated with an institute covered by a cooperation agreement with CERN DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain ICCUB, Universitat de Barcelona, Barcelona, Spain Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain European Organization for Nuclear Research (CERN), Geneva, Switzerland Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland Physik-Institut, Universität Zürich, Zürich, Switzerland NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine University of Birmingham, Birmingham, United Kingdom H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom Department of Physics, University of Warwick, Coventry, United Kingdom STFC Rutherford Appleton Laboratory, Didcot, United Kingdom School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom Imperial College London, London, United Kingdom Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom Department of Physics, University of Oxford, Oxford, United Kingdom Massachusetts Institute of Technology, Cambridge, Massachusetts, USA University of Cincinnati, Cincinnati, Ohio, USA University of Maryland, College Park, Maryland, USA Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA Syracuse University, Syracuse, New York, USA Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil) School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China) Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China) School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France) Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany) Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland) Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland) Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom) University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA) Departement de Physique Nucleaire (SPhN), Gif-Sur-Yvette, France
M P Blago Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
T Blake Department of Physics, University of Warwick, Coventry, United Kingdom
F Blanc Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
J E Blank Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
S Blusk Syracuse University, Syracuse, New York, USA
D Bobulska School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
V Bocharnikov Affiliated with an institute covered by a cooperation agreement with CERN
J A Boelhauve Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
O Boente Garcia Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
T Boettcher University of Cincinnati, Cincinnati, Ohio, USA
A Bohare School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
A Boldyrev Affiliated with an institute covered by a cooperation agreement with CERN
C S Bolognani Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
R Bolzonella INFN Sezione di Ferrara, Ferrara, Italy
N Bondar Affiliated with an institute covered by a cooperation agreement with CERN
F Borgato Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Borghi Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
M Borsato INFN Sezione di Milano-Bicocca, Milano, Italy
J T Borsuk Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
S A Bouchiba Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
T J V Bowcock Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
A Boyer European Organization for Nuclear Research (CERN), Geneva, Switzerland
C Bozzi INFN Sezione di Ferrara, Ferrara, Italy
M J Bradley Imperial College London, London, United Kingdom
S Braun University of Maryland, College Park, Maryland, USA
A Brea Rodriguez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
N Breer Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
J Brodzicka Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
A Brossa Gonzalo Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
J Brown Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
D Brundu INFN Sezione di Cagliari, Monserrato, Italy
A Buonaura Physik-Institut, Universität Zürich, Zürich, Switzerland
L Buonincontri Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
A T Burke Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
C Burr European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Bursche Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
A Butkevich Affiliated with an institute covered by a cooperation agreement with CERN
J S Butter Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
J Buytaert European Organization for Nuclear Research (CERN), Geneva, Switzerland
W Byczynski European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Cadeddu INFN Sezione di Cagliari, Monserrato, Italy
H Cai School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
R Calabrese INFN Sezione di Ferrara, Ferrara, Italy
L Calefice Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
S Cali INFN Laboratori Nazionali di Frascati, Frascati, Italy
M Calvi INFN Sezione di Milano-Bicocca, Milano, Italy
M Calvo Gomez DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
J Cambon Bouzas Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
P Campana INFN Laboratori Nazionali di Frascati, Frascati, Italy
D H Campora Perez Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
A F Campoverde Quezada University of Chinese Academy of Sciences, Beijing, China
S Capelli INFN Sezione di Milano-Bicocca, Milano, Italy
L Capriotti INFN Sezione di Ferrara, Ferrara, Italy
R Caravaca-Mora Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica
A Carbone INFN Sezione di Bologna, Bologna, Italy
L Carcedo Salgado Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
R Cardinale INFN Sezione di Genova, Genova, Italy
A Cardini INFN Sezione di Cagliari, Monserrato, Italy
P Carniti INFN Sezione di Milano-Bicocca, Milano, Italy
L Carus Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A Casais Vidal Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
R Caspary Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
G Casse Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
J Castro Godinez Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica
M Cattaneo European Organization for Nuclear Research (CERN), Geneva, Switzerland
G Cavallero INFN Sezione di Ferrara, Ferrara, Italy
V Cavallini INFN Sezione di Ferrara, Ferrara, Italy
S Celani Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
J Cerasoli Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
D Cervenkov Department of Physics, University of Oxford, Oxford, United Kingdom
S Cesare INFN Sezione di Milano, Milano, Italy
A J Chadwick Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
I Chahrour University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
M Charles LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
Ph Charpentier European Organization for Nuclear Research (CERN), Geneva, Switzerland
C A Chavez Barajas Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
M Chefdeville Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
C Chen Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
S Chen Institute Of High Energy Physics (IHEP), Beijing, China
A Chernov Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
S Chernyshenko Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
V Chobanova Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
S Cholak Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M Chrzaszcz Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
A Chubykin Affiliated with an institute covered by a cooperation agreement with CERN
V Chulikov Affiliated with an institute covered by a cooperation agreement with CERN
P Ciambrone INFN Laboratori Nazionali di Frascati, Frascati, Italy
M F Cicala Department of Physics, University of Warwick, Coventry, United Kingdom
X Cid Vidal Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
G Ciezarek European Organization for Nuclear Research (CERN), Geneva, Switzerland
P Cifra European Organization for Nuclear Research (CERN), Geneva, Switzerland
P E L Clarke School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Clemencic European Organization for Nuclear Research (CERN), Geneva, Switzerland
H V Cliff Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
J Closier European Organization for Nuclear Research (CERN), Geneva, Switzerland
J L Cobbledick Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
C Cocha Toapaxi Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
V Coco European Organization for Nuclear Research (CERN), Geneva, Switzerland
J Cogan Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
E Cogneras Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
L Cojocariu Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
P Collins European Organization for Nuclear Research (CERN), Geneva, Switzerland
T Colombo European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Comerma-Montells ICCUB, Universitat de Barcelona, Barcelona, Spain
L Congedo INFN Sezione di Bari, Bari, Italy
A Contu INFN Sezione di Cagliari, Monserrato, Italy
N Cooke School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
I Corredoira Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
A Correia LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
G Corti European Organization for Nuclear Research (CERN), Geneva, Switzerland
J J Cottee Meldrum H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
B Couturier European Organization for Nuclear Research (CERN), Geneva, Switzerland
D C Craik Physik-Institut, Universität Zürich, Zürich, Switzerland
M Cruz Torres Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
R Currie School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
C L Da Silva Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA
S Dadabaev Affiliated with an institute covered by a cooperation agreement with CERN
L Dai School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
X Dai School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
E Dall'Occo Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
J Dalseno Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
C D'Ambrosio European Organization for Nuclear Research (CERN), Geneva, Switzerland
J Daniel Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
A Danilina Affiliated with an institute covered by a cooperation agreement with CERN
P d'Argent INFN Sezione di Bari, Bari, Italy
A Davidson Department of Physics, University of Warwick, Coventry, United Kingdom
J E Davies Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
A Davis Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
O De Aguiar Francisco Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
C De Angelis INFN Sezione di Cagliari, Monserrato, Italy
J de Boer Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
K De Bruyn Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
S De Capua Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
M De Cian Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany European Organization for Nuclear Research (CERN), Geneva, Switzerland
U De Freitas Carneiro Da Graca Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
E De Lucia INFN Laboratori Nazionali di Frascati, Frascati, Italy
J M De Miranda Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
L De Paula Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
M De Serio INFN Sezione di Bari, Bari, Italy
D De Simone Physik-Institut, Universität Zürich, Zürich, Switzerland
P De Simone INFN Laboratori Nazionali di Frascati, Frascati, Italy
F De Vellis Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
J A de Vries Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
F Debernardis INFN Sezione di Bari, Bari, Italy
D Decamp Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
V Dedu Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
L Del Buono LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
B Delaney Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
H-P Dembinski Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
J Deng Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
V Denysenko Physik-Institut, Universität Zürich, Zürich, Switzerland
O Deschamps Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
F Dettori INFN Sezione di Cagliari, Monserrato, Italy
B Dey Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland)
P Di Nezza INFN Laboratori Nazionali di Frascati, Frascati, Italy
I Diachkov Affiliated with an institute covered by a cooperation agreement with CERN
S Didenko Affiliated with an institute covered by a cooperation agreement with CERN
S Ding Syracuse University, Syracuse, New York, USA
V Dobishuk Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
A D Docheva School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A Dolmatov Affiliated with an institute covered by a cooperation agreement with CERN
C Dong Center for High Energy Physics, Tsinghua University, Beijing, China
A M Donohoe School of Physics, University College Dublin, Dublin, Ireland
F Dordei INFN Sezione di Cagliari, Monserrato, Italy
A C Dos Reis Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
L Douglas School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A G Downes Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
W Duan Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
P Duda Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
M W Dudek Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
L Dufour European Organization for Nuclear Research (CERN), Geneva, Switzerland
V Duk INFN Sezione di Perugia, Perugia, Italy
P Durante European Organization for Nuclear Research (CERN), Geneva, Switzerland
M M Duras Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
J M Durham Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA
A Dziurda Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
A Dzyuba Affiliated with an institute covered by a cooperation agreement with CERN
S Easo European Organization for Nuclear Research (CERN), Geneva, Switzerland STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
E Eckstein Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
U Egede School of Physics and Astronomy, Monash University, Melbourne, Australia
A Egorychev Affiliated with an institute covered by a cooperation agreement with CERN
V Egorychev Affiliated with an institute covered by a cooperation agreement with CERN
C Eirea Orro Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
S Eisenhardt School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
E Ejopu Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
S Ek-In Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
L Eklund Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
M Elashri University of Cincinnati, Cincinnati, Ohio, USA
J Ellbracht Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
S Ely Imperial College London, London, United Kingdom
A Ene Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
E Epple University of Cincinnati, Cincinnati, Ohio, USA
S Escher I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
J Eschle Physik-Institut, Universität Zürich, Zürich, Switzerland
S Esen Physik-Institut, Universität Zürich, Zürich, Switzerland
T Evans Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
F Fabiano INFN Sezione di Cagliari, Monserrato, Italy European Organization for Nuclear Research (CERN), Geneva, Switzerland
L N Falcao Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
Y Fan University of Chinese Academy of Sciences, Beijing, China
B Fang Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
L Fantini INFN Sezione di Perugia, Perugia, Italy
M Faria Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
K Farmer School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
D Fazzini INFN Sezione di Milano-Bicocca, Milano, Italy
L Felkowski Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
M Feng Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
M Feo European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Fernandez Gomez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
A D Fernez University of Maryland, College Park, Maryland, USA
F Ferrari INFN Sezione di Bologna, Bologna, Italy
F Ferreira Rodrigues Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
S Ferreres Sole Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
M Ferrillo Physik-Institut, Universität Zürich, Zürich, Switzerland
M Ferro-Luzzi European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Filippov Affiliated with an institute covered by a cooperation agreement with CERN
R A Fini INFN Sezione di Bari, Bari, Italy
M Fiorini INFN Sezione di Ferrara, Ferrara, Italy
M Firlej AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
K M Fischer Department of Physics, University of Oxford, Oxford, United Kingdom
D S Fitzgerald University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
C Fitzpatrick Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
T Fiutowski AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
F Fleuret Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
M Fontana INFN Sezione di Bologna, Bologna, Italy
F Fontanelli INFN Sezione di Genova, Genova, Italy
L F Foreman Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
R Forty European Organization for Nuclear Research (CERN), Geneva, Switzerland
D Foulds-Holt Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
M Franco Sevilla University of Maryland, College Park, Maryland, USA
M Frank European Organization for Nuclear Research (CERN), Geneva, Switzerland
E Franzoso INFN Sezione di Ferrara, Ferrara, Italy
G Frau Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
C Frei European Organization for Nuclear Research (CERN), Geneva, Switzerland
D A Friday Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
L Frontini INFN Sezione di Milano, Milano, Italy
J Fu University of Chinese Academy of Sciences, Beijing, China
Q Fuehring Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
Y Fujii School of Physics and Astronomy, Monash University, Melbourne, Australia
T Fulghesu LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
E Gabriel Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
G Galati INFN Sezione di Bari, Bari, Italy
M D Galati Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
A Gallas Torreira Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
D Galli INFN Sezione di Bologna, Bologna, Italy
S Gambetta European Organization for Nuclear Research (CERN), Geneva, Switzerland School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Gandelman Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
P Gandini INFN Sezione di Milano, Milano, Italy
H Gao University of Chinese Academy of Sciences, Beijing, China
R Gao Department of Physics, University of Oxford, Oxford, United Kingdom
Y Gao Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Y Gao School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
Y Gao Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
M Garau INFN Sezione di Cagliari, Monserrato, Italy
L M Garcia Martin Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
P Garcia Moreno ICCUB, Universitat de Barcelona, Barcelona, Spain
J García Pardiñas European Organization for Nuclear Research (CERN), Geneva, Switzerland
B Garcia Plana Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
K G Garg Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
L Garrido ICCUB, Universitat de Barcelona, Barcelona, Spain
C Gaspar European Organization for Nuclear Research (CERN), Geneva, Switzerland
R E Geertsema Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
L L Gerken Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
E Gersabeck Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
M Gersabeck Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
T Gershon Department of Physics, University of Warwick, Coventry, United Kingdom
Z Ghorbanimoghaddam H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
L Giambastiani Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
F I Giasemis LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
V Gibson Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
H K Giemza National Center for Nuclear Research (NCBJ), Warsaw, Poland
A L Gilman Department of Physics, University of Oxford, Oxford, United Kingdom
M Giovannetti INFN Laboratori Nazionali di Frascati, Frascati, Italy
A Gioventù ICCUB, Universitat de Barcelona, Barcelona, Spain
P Gironella Gironell ICCUB, Universitat de Barcelona, Barcelona, Spain
C Giugliano INFN Sezione di Ferrara, Ferrara, Italy
M A Giza Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
E L Gkougkousis Imperial College London, London, United Kingdom
F C Glaser Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
V V Gligorov LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
C Göbel Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil)
E Golobardes DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
D Golubkov Affiliated with an institute covered by a cooperation agreement with CERN
A Golutvin Affiliated with an institute covered by a cooperation agreement with CERN European Organization for Nuclear Research (CERN), Geneva, Switzerland Imperial College London, London, United Kingdom
A Gomes Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
S Gomez Fernandez ICCUB, Universitat de Barcelona, Barcelona, Spain
F Goncalves Abrantes Department of Physics, University of Oxford, Oxford, United Kingdom
M Goncerz Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
G Gong Center for High Energy Physics, Tsinghua University, Beijing, China
J A Gooding Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
I V Gorelov Affiliated with an institute covered by a cooperation agreement with CERN
C Gotti INFN Sezione di Milano-Bicocca, Milano, Italy
J P Grabowski Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
L A Granado Cardoso European Organization for Nuclear Research (CERN), Geneva, Switzerland
E Graugés ICCUB, Universitat de Barcelona, Barcelona, Spain
E Graverini Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
L Grazette Department of Physics, University of Warwick, Coventry, United Kingdom
G Graziani School of Physics and Astronomy, Monash University, Melbourne, Australia Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil Center for High Energy Physics, Tsinghua University, Beijing, China Institute Of High Energy Physics (IHEP), Beijing, China School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China University of Chinese Academy of Sciences, Beijing, China Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany School of Physics, University College Dublin, Dublin, Ireland INFN Sezione di Bari, Bari, Italy INFN Sezione di Bologna, Bologna, Italy INFN Sezione di Ferrara, Ferrara, Italy INFN Sezione di Firenze, Firenze, Italy INFN Laboratori Nazionali di Frascati, Frascati, Italy INFN Sezione di Genova, Genova, Italy INFN Sezione di Milano, Milano, Italy INFN Sezione di Milano-Bicocca, Milano, Italy INFN Sezione di Cagliari, Monserrato, Italy Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy INFN Sezione di Perugia, Perugia, Italy INFN Sezione di Pisa, Pisa, Italy INFN Sezione di Roma La Sapienza, Roma, Italy INFN Sezione di Roma Tor Vergata, Roma, Italy Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland National Center for Nuclear Research (NCBJ), Warsaw, Poland Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania Affiliated with an institute covered by a cooperation agreement with CERN DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain ICCUB, Universitat de Barcelona, Barcelona, Spain Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain European Organization for Nuclear Research (CERN), Geneva, Switzerland Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland Physik-Institut, Universität Zürich, Zürich, Switzerland NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine University of Birmingham, Birmingham, United Kingdom H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom Department of Physics, University of Warwick, Coventry, United Kingdom STFC Rutherford Appleton Laboratory, Didcot, United Kingdom School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom Imperial College London, London, United Kingdom Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom Department of Physics, University of Oxford, Oxford, United Kingdom Massachusetts Institute of Technology, Cambridge, Massachusetts, USA University of Cincinnati, Cincinnati, Ohio, USA University of Maryland, College Park, Maryland, USA Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA Syracuse University, Syracuse, New York, USA Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil) School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China) Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China) School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France) Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany) Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland) Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland) Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom) University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA) Departement de Physique Nucleaire (SPhN), Gif-Sur-Yvette, France
A T Grecu Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
L M Greeven Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
N A Grieser University of Cincinnati, Cincinnati, Ohio, USA
L Grillo School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
S Gromov Affiliated with an institute covered by a cooperation agreement with CERN
C Gu Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
M Guarise INFN Sezione di Ferrara, Ferrara, Italy
M Guittiere Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
V Guliaeva Affiliated with an institute covered by a cooperation agreement with CERN
P A Günther Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A-K Guseinov Affiliated with an institute covered by a cooperation agreement with CERN
E Gushchin Affiliated with an institute covered by a cooperation agreement with CERN
Y Guz School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China Affiliated with an institute covered by a cooperation agreement with CERN European Organization for Nuclear Research (CERN), Geneva, Switzerland
T Gys European Organization for Nuclear Research (CERN), Geneva, Switzerland
T Hadavizadeh School of Physics and Astronomy, Monash University, Melbourne, Australia
C Hadjivasiliou University of Maryland, College Park, Maryland, USA
G Haefeli Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
C Haen European Organization for Nuclear Research (CERN), Geneva, Switzerland
J Haimberger European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Hajheidari European Organization for Nuclear Research (CERN), Geneva, Switzerland
T Halewood-Leagas Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
M M Halvorsen European Organization for Nuclear Research (CERN), Geneva, Switzerland
P M Hamilton University of Maryland, College Park, Maryland, USA
J Hammerich Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
Q Han Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
X Han Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
S Hansmann-Menzemer Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
L Hao University of Chinese Academy of Sciences, Beijing, China
N Harnew Department of Physics, University of Oxford, Oxford, United Kingdom
T Harrison Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
M Hartmann Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
C Hasse European Organization for Nuclear Research (CERN), Geneva, Switzerland
J He University of Chinese Academy of Sciences, Beijing, China
K Heijhoff Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
F Hemmer European Organization for Nuclear Research (CERN), Geneva, Switzerland
C Henderson University of Cincinnati, Cincinnati, Ohio, USA
R D L Henderson School of Physics and Astronomy, Monash University, Melbourne, Australia Department of Physics, University of Warwick, Coventry, United Kingdom
A M Hennequin European Organization for Nuclear Research (CERN), Geneva, Switzerland
K Hennessy Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
L Henry Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
J Herd Imperial College London, London, United Kingdom
J Heuel I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
A Hicheur Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
D Hill Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
S E Hollitt Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
J Horswill Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
R Hou Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Y Hou Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
N Howarth Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
J Hu Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
J Hu Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
W Hu School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
X Hu Center for High Energy Physics, Tsinghua University, Beijing, China
W Huang University of Chinese Academy of Sciences, Beijing, China
W Hulsbergen Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
R J Hunter Department of Physics, University of Warwick, Coventry, United Kingdom
M Hushchyn Affiliated with an institute covered by a cooperation agreement with CERN
D Hutchcroft Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
M Idzik AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
D Ilin Affiliated with an institute covered by a cooperation agreement with CERN
P Ilten University of Cincinnati, Cincinnati, Ohio, USA
A Inglessi Affiliated with an institute covered by a cooperation agreement with CERN
A Iniukhin Affiliated with an institute covered by a cooperation agreement with CERN
A Ishteev Affiliated with an institute covered by a cooperation agreement with CERN
K Ivshin Affiliated with an institute covered by a cooperation agreement with CERN
R Jacobsson European Organization for Nuclear Research (CERN), Geneva, Switzerland
H Jage I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
S J Jaimes Elles Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
S Jakobsen European Organization for Nuclear Research (CERN), Geneva, Switzerland
E Jans Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
B K Jashal Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
A Jawahery University of Maryland, College Park, Maryland, USA
V Jevtic Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
E Jiang University of Maryland, College Park, Maryland, USA
X Jiang Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
Y Jiang University of Chinese Academy of Sciences, Beijing, China
Y J Jiang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
M John Department of Physics, University of Oxford, Oxford, United Kingdom
D Johnson University of Birmingham, Birmingham, United Kingdom
C R Jones Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
T P Jones Department of Physics, University of Warwick, Coventry, United Kingdom
S Joshi National Center for Nuclear Research (NCBJ), Warsaw, Poland
B Jost European Organization for Nuclear Research (CERN), Geneva, Switzerland
N Jurik European Organization for Nuclear Research (CERN), Geneva, Switzerland
I Juszczak Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
D Kaminaris Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
S Kandybei NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine
Y Kang Center for High Energy Physics, Tsinghua University, Beijing, China
M Karacson European Organization for Nuclear Research (CERN), Geneva, Switzerland
D Karpenkov Affiliated with an institute covered by a cooperation agreement with CERN
M Karpov Affiliated with an institute covered by a cooperation agreement with CERN
A M Kauniskangas Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
J W Kautz University of Cincinnati, Cincinnati, Ohio, USA
F Keizer European Organization for Nuclear Research (CERN), Geneva, Switzerland
D M Keller Syracuse University, Syracuse, New York, USA
M Kenzie Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
T Ketel Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
B Khanji Syracuse University, Syracuse, New York, USA
A Kharisova Affiliated with an institute covered by a cooperation agreement with CERN
S Kholodenko INFN Sezione di Pisa, Pisa, Italy
G Khreich Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
T Kirn I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
V S Kirsebom Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
O Kitouni Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
S Klaver Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
N Kleijne INFN Sezione di Pisa, Pisa, Italy
K Klimaszewski National Center for Nuclear Research (NCBJ), Warsaw, Poland
M R Kmiec National Center for Nuclear Research (NCBJ), Warsaw, Poland
S Koliiev Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
L Kolk Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
A Konoplyannikov Affiliated with an institute covered by a cooperation agreement with CERN
P Kopciewicz AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland European Organization for Nuclear Research (CERN), Geneva, Switzerland
P Koppenburg Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
M Korolev Affiliated with an institute covered by a cooperation agreement with CERN
I Kostiuk Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
O Kot Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
S Kotriakhova School of Physics and Astronomy, Monash University, Melbourne, Australia Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil Center for High Energy Physics, Tsinghua University, Beijing, China Institute Of High Energy Physics (IHEP), Beijing, China School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China University of Chinese Academy of Sciences, Beijing, China Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany School of Physics, University College Dublin, Dublin, Ireland INFN Sezione di Bari, Bari, Italy INFN Sezione di Bologna, Bologna, Italy INFN Sezione di Ferrara, Ferrara, Italy INFN Sezione di Firenze, Firenze, Italy INFN Laboratori Nazionali di Frascati, Frascati, Italy INFN Sezione di Genova, Genova, Italy INFN Sezione di Milano, Milano, Italy INFN Sezione di Milano-Bicocca, Milano, Italy INFN Sezione di Cagliari, Monserrato, Italy Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy INFN Sezione di Perugia, Perugia, Italy INFN Sezione di Pisa, Pisa, Italy INFN Sezione di Roma La Sapienza, Roma, Italy INFN Sezione di Roma Tor Vergata, Roma, Italy Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland National Center for Nuclear Research (NCBJ), Warsaw, Poland Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania Affiliated with an institute covered by a cooperation agreement with CERN DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain ICCUB, Universitat de Barcelona, Barcelona, Spain Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain European Organization for Nuclear Research (CERN), Geneva, Switzerland Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland Physik-Institut, Universität Zürich, Zürich, Switzerland NSC Kharkiv Institute of Physics and Technology (NSC KIPT), Kharkiv, Ukraine Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine University of Birmingham, Birmingham, United Kingdom H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom Department of Physics, University of Warwick, Coventry, United Kingdom STFC Rutherford Appleton Laboratory, Didcot, United Kingdom School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom Imperial College London, London, United Kingdom Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom Department of Physics, University of Oxford, Oxford, United Kingdom Massachusetts Institute of Technology, Cambridge, Massachusetts, USA University of Cincinnati, Cincinnati, Ohio, USA University of Maryland, College Park, Maryland, USA Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA Syracuse University, Syracuse, New York, USA Pontifícia Universidade Católica do Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil (associated with Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil) School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China) Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China) School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China) Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France) Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany) Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland) Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands) Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland) Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom) University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA) Departement de Physique Nucleaire (SPhN), Gif-Sur-Yvette, France
A Kozachuk Affiliated with an institute covered by a cooperation agreement with CERN
P Kravchenko Affiliated with an institute covered by a cooperation agreement with CERN
L Kravchuk Affiliated with an institute covered by a cooperation agreement with CERN
M Kreps Department of Physics, University of Warwick, Coventry, United Kingdom
S Kretzschmar I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
P Krokovny Affiliated with an institute covered by a cooperation agreement with CERN
W Krupa Syracuse University, Syracuse, New York, USA
W Krzemien National Center for Nuclear Research (NCBJ), Warsaw, Poland
J Kubat Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
S Kubis Tadeusz Kosciuszko Cracow University of Technology, Cracow, Poland (associated with Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland)
W Kucewicz Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
M Kucharczyk Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
V Kudryavtsev Affiliated with an institute covered by a cooperation agreement with CERN
E Kulikova Affiliated with an institute covered by a cooperation agreement with CERN
A Kupsc Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
B K Kutsenko Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
D Lacarrere European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Lai INFN Sezione di Cagliari, Monserrato, Italy
A Lampis INFN Sezione di Cagliari, Monserrato, Italy
D Lancierini Physik-Institut, Universität Zürich, Zürich, Switzerland
C Landesa Gomez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
J J Lane School of Physics and Astronomy, Monash University, Melbourne, Australia
R Lane H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
C Langenbruch Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
J Langer Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
O Lantwin Affiliated with an institute covered by a cooperation agreement with CERN
T Latham Department of Physics, University of Warwick, Coventry, United Kingdom
F Lazzari INFN Sezione di Pisa, Pisa, Italy
C Lazzeroni University of Birmingham, Birmingham, United Kingdom
R Le Gac Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
S H Lee University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
R Lefèvre Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
A Leflat Affiliated with an institute covered by a cooperation agreement with CERN
S Legotin Affiliated with an institute covered by a cooperation agreement with CERN
M Lehuraux Department of Physics, University of Warwick, Coventry, United Kingdom
O Leroy Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
T Lesiak Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
B Leverington Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A Li Center for High Energy Physics, Tsinghua University, Beijing, China
H Li Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
K Li Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
L Li Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
P Li European Organization for Nuclear Research (CERN), Geneva, Switzerland
P-R Li Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China)
S Li Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
T Li Institute Of High Energy Physics (IHEP), Beijing, China
T Li Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
Y Li Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Y Li Institute Of High Energy Physics (IHEP), Beijing, China
Z Li Syracuse University, Syracuse, New York, USA
Z Lian Center for High Energy Physics, Tsinghua University, Beijing, China
X Liang Syracuse University, Syracuse, New York, USA
C Lin University of Chinese Academy of Sciences, Beijing, China
T Lin STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
R Lindner European Organization for Nuclear Research (CERN), Geneva, Switzerland
V Lisovskyi Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
R Litvinov INFN Sezione di Cagliari, Monserrato, Italy
G Liu Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
H Liu University of Chinese Academy of Sciences, Beijing, China
K Liu Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China)
Q Liu University of Chinese Academy of Sciences, Beijing, China
S Liu Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
Y Liu School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
Y Liu Lanzhou University, Lanzhou, China (associated with Institute Of High Energy Physics (IHEP), Beijing, China)
Y L Liu Imperial College London, London, United Kingdom
A Lobo Salvia ICCUB, Universitat de Barcelona, Barcelona, Spain
A Loi INFN Sezione di Cagliari, Monserrato, Italy
J Lomba Castro Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
T Long Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
J H Lopes Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
A Lopez Huertas ICCUB, Universitat de Barcelona, Barcelona, Spain
S López Soliño Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
G H Lovell Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
C Lucarelli INFN Sezione di Firenze, Firenze, Italy
D Lucchesi Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
S Luchuk Affiliated with an institute covered by a cooperation agreement with CERN
M Lucio Martinez Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
V Lukashenko Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
Y Luo Center for High Energy Physics, Tsinghua University, Beijing, China
A Lupato Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
E Luppi INFN Sezione di Ferrara, Ferrara, Italy
K Lynch School of Physics, University College Dublin, Dublin, Ireland
X-R Lyu University of Chinese Academy of Sciences, Beijing, China
G M Ma Center for High Energy Physics, Tsinghua University, Beijing, China
R Ma University of Chinese Academy of Sciences, Beijing, China
S Maccolini Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
F Machefert Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
F Maciuc Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
I Mackay Department of Physics, University of Oxford, Oxford, United Kingdom
L R Madhan Mohan Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
M M Madurai University of Birmingham, Birmingham, United Kingdom
A Maevskiy Affiliated with an institute covered by a cooperation agreement with CERN
D Magdalinski Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
D Maisuzenko Affiliated with an institute covered by a cooperation agreement with CERN
M W Majewski AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
J J Malczewski Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
S Malde Department of Physics, University of Oxford, Oxford, United Kingdom
B Malecki Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland European Organization for Nuclear Research (CERN), Geneva, Switzerland
L Malentacca European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Malinin Affiliated with an institute covered by a cooperation agreement with CERN
T Maltsev Affiliated with an institute covered by a cooperation agreement with CERN
G Manca INFN Sezione di Cagliari, Monserrato, Italy
G Mancinelli Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
C Mancuso Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France INFN Sezione di Milano, Milano, Italy
R Manera Escalero ICCUB, Universitat de Barcelona, Barcelona, Spain
D Manuzzi INFN Sezione di Bologna, Bologna, Italy
D Marangotto INFN Sezione di Milano, Milano, Italy
J F Marchand Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
R Marchevski Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
U Marconi INFN Sezione di Bologna, Bologna, Italy
S Mariani European Organization for Nuclear Research (CERN), Geneva, Switzerland
C Marin Benito ICCUB, Universitat de Barcelona, Barcelona, Spain European Organization for Nuclear Research (CERN), Geneva, Switzerland
J Marks Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A M Marshall H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
P J Marshall Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
G Martelli INFN Sezione di Perugia, Perugia, Italy
G Martellotti INFN Sezione di Roma La Sapienza, Roma, Italy
L Martinazzoli European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Martinelli INFN Sezione di Milano-Bicocca, Milano, Italy
D Martinez Santos Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
F Martinez Vidal Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
A Massafferri Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
M Materok I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
R Matev European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Mathad Physik-Institut, Universität Zürich, Zürich, Switzerland
V Matiunin Affiliated with an institute covered by a cooperation agreement with CERN
C Matteuzzi Syracuse University, Syracuse, New York, USA
K R Mattioli Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
A Mauri Imperial College London, London, United Kingdom
E Maurice Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
J Mauricio ICCUB, Universitat de Barcelona, Barcelona, Spain
P Mayencourt Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M Mazurek European Organization for Nuclear Research (CERN), Geneva, Switzerland
M McCann Imperial College London, London, United Kingdom
L Mcconnell School of Physics, University College Dublin, Dublin, Ireland
T H McGrath Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
N T McHugh School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A McNab Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
R McNulty School of Physics, University College Dublin, Dublin, Ireland
B Meadows University of Cincinnati, Cincinnati, Ohio, USA
G Meier Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
D Melnychuk National Center for Nuclear Research (NCBJ), Warsaw, Poland
M Merk Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
A Merli INFN Sezione di Milano, Milano, Italy
L Meyer Garcia Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
D Miao Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
H Miao University of Chinese Academy of Sciences, Beijing, China
M Mikhasenko Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
D A Milanes Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
A Minotti INFN Sezione di Milano-Bicocca, Milano, Italy
E Minucci Syracuse University, Syracuse, New York, USA
T Miralles Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
S E Mitchell School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
B Mitreska Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
D S Mitzel Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
A Modak STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
A Mödden Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
R A Mohammed Department of Physics, University of Oxford, Oxford, United Kingdom
R D Moise I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
S Mokhnenko Affiliated with an institute covered by a cooperation agreement with CERN
T Mombächer European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Monk School of Physics and Astronomy, Monash University, Melbourne, Australia Department of Physics, University of Warwick, Coventry, United Kingdom
I A Monroy Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
S Monteil Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
A Morcillo Gomez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
G Morello INFN Laboratori Nazionali di Frascati, Frascati, Italy
M J Morello INFN Sezione di Pisa, Pisa, Italy
M P Morgenthaler Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
J Moron AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
A B Morris European Organization for Nuclear Research (CERN), Geneva, Switzerland
A G Morris Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
R Mountain Syracuse University, Syracuse, New York, USA
H Mu Center for High Energy Physics, Tsinghua University, Beijing, China
Z M Mu School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
E Muhammad Department of Physics, University of Warwick, Coventry, United Kingdom
F Muheim School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Mulder Van Swinderen Institute, University of Groningen, Groningen, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
K Müller Physik-Institut, Universität Zürich, Zürich, Switzerland
F Mũnoz-Rojas Consejo Nacional de Rectores (CONARE), San Jose, Costa Rica
R Murta Imperial College London, London, United Kingdom
P Naik Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
T Nakada Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
R Nandakumar STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
T Nanut European Organization for Nuclear Research (CERN), Geneva, Switzerland
I Nasteva Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
M Needham School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
N Neri INFN Sezione di Milano, Milano, Italy
S Neubert Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
N Neufeld European Organization for Nuclear Research (CERN), Geneva, Switzerland
P Neustroev Affiliated with an institute covered by a cooperation agreement with CERN
R Newcombe Imperial College London, London, United Kingdom
J Nicolini Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
D Nicotra Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
E M Niel Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
N Nikitin Affiliated with an institute covered by a cooperation agreement with CERN
P Nogga Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
N S Nolte Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
C Normand Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France INFN Sezione di Cagliari, Monserrato, Italy
J Novoa Fernandez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
G Nowak University of Cincinnati, Cincinnati, Ohio, USA
C Nunez University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
H N Nur School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A Oblakowska-Mucha AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
V Obraztsov Affiliated with an institute covered by a cooperation agreement with CERN
T Oeser I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
S Okamura INFN Sezione di Ferrara, Ferrara, Italy European Organization for Nuclear Research (CERN), Geneva, Switzerland
R Oldeman INFN Sezione di Cagliari, Monserrato, Italy
F Oliva School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Olocco Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
C J G Onderwater Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
R H O'Neil School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
J M Otalora Goicochea Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
T Ovsiannikova Affiliated with an institute covered by a cooperation agreement with CERN
P Owen Physik-Institut, Universität Zürich, Zürich, Switzerland
A Oyanguren Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
O Ozcelik School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
K O Padeken Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
B Pagare Department of Physics, University of Warwick, Coventry, United Kingdom
P R Pais Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
T Pajero Department of Physics, University of Oxford, Oxford, United Kingdom
A Palano INFN Sezione di Bari, Bari, Italy
M Palutan INFN Laboratori Nazionali di Frascati, Frascati, Italy
G Panshin Affiliated with an institute covered by a cooperation agreement with CERN
L Paolucci Department of Physics, University of Warwick, Coventry, United Kingdom
A Papanestis STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
M Pappagallo INFN Sezione di Bari, Bari, Italy
L L Pappalardo INFN Sezione di Ferrara, Ferrara, Italy
C Pappenheimer University of Cincinnati, Cincinnati, Ohio, USA
C Parkes Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
B Passalacqua INFN Sezione di Ferrara, Ferrara, Italy
G Passaleva INFN Sezione di Firenze, Firenze, Italy
D Passaro INFN Sezione di Pisa, Pisa, Italy
A Pastore INFN Sezione di Bari, Bari, Italy
M Patel Imperial College London, London, United Kingdom
J Patoc Department of Physics, University of Oxford, Oxford, United Kingdom
C Patrignani INFN Sezione di Bologna, Bologna, Italy
C J Pawley Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
A Pellegrino Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
M Pepe Altarelli INFN Laboratori Nazionali di Frascati, Frascati, Italy
S Perazzini INFN Sezione di Bologna, Bologna, Italy
D Pereima Affiliated with an institute covered by a cooperation agreement with CERN
A Pereiro Castro Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
P Perret Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
A Perro European Organization for Nuclear Research (CERN), Geneva, Switzerland
K Petridis H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
A Petrolini INFN Sezione di Genova, Genova, Italy
S Petrucci School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
H Pham Syracuse University, Syracuse, New York, USA
L Pica INFN Sezione di Pisa, Pisa, Italy
M Piccini INFN Sezione di Perugia, Perugia, Italy
B Pietrzyk Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
G Pietrzyk Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
D Pinci INFN Sezione di Roma La Sapienza, Roma, Italy
F Pisani European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Pizzichemi INFN Sezione di Milano-Bicocca, Milano, Italy
V Placinta Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest-Magurele, Romania
M Plo Casasus Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
F Polci LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Poli Lener INFN Laboratori Nazionali di Frascati, Frascati, Italy
A Poluektov Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
N Polukhina Affiliated with an institute covered by a cooperation agreement with CERN
I Polyakov European Organization for Nuclear Research (CERN), Geneva, Switzerland
E Polycarpo Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
S Ponce European Organization for Nuclear Research (CERN), Geneva, Switzerland
D Popov University of Chinese Academy of Sciences, Beijing, China
S Poslavskii Affiliated with an institute covered by a cooperation agreement with CERN
K Prasanth Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
C Prouve Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
V Pugatch Institute for Nuclear Research of the National Academy of Sciences (KINR), Kyiv, Ukraine
V Puill Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
G Punzi INFN Sezione di Pisa, Pisa, Italy
H R Qi Center for High Energy Physics, Tsinghua University, Beijing, China
W Qian University of Chinese Academy of Sciences, Beijing, China
N Qin Center for High Energy Physics, Tsinghua University, Beijing, China
S Qu Center for High Energy Physics, Tsinghua University, Beijing, China
R Quagliani Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
R I Rabadan Trejo Department of Physics, University of Warwick, Coventry, United Kingdom
B Rachwal AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
J H Rademacker H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
M Rama INFN Sezione di Pisa, Pisa, Italy
M Ramírez García University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
M Ramos Pernas Department of Physics, University of Warwick, Coventry, United Kingdom
M S Rangel Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
F Ratnikov Affiliated with an institute covered by a cooperation agreement with CERN
G Raven Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
M Rebollo De Miguel Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
F Redi European Organization for Nuclear Research (CERN), Geneva, Switzerland
J Reich H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
F Reiss Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
Z Ren University of Chinese Academy of Sciences, Beijing, China
P K Resmi Department of Physics, University of Oxford, Oxford, United Kingdom
R Ribatti INFN Sezione di Pisa, Pisa, Italy
G R Ricart Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France Departement de Physique Nucleaire (SPhN), Gif-Sur-Yvette, France
D Riccardi INFN Sezione di Pisa, Pisa, Italy
S Ricciardi STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
K Richardson Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
M Richardson-Slipper School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
K Rinnert Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
P Robbe Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
G Robertson School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
E Rodrigues European Organization for Nuclear Research (CERN), Geneva, Switzerland Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
E Rodriguez Fernandez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
J A Rodriguez Lopez Departamento de Fisica, Universidad Nacional de Colombia, Bogota, Colombia (associated with LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France)
E Rodriguez Rodriguez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
A Rogovskiy STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
D L Rolf European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Rollings Department of Physics, University of Oxford, Oxford, United Kingdom
P Roloff European Organization for Nuclear Research (CERN), Geneva, Switzerland
V Romanovskiy Affiliated with an institute covered by a cooperation agreement with CERN
M Romero Lamas Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
A Romero Vidal Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
G Romolini INFN Sezione di Ferrara, Ferrara, Italy
F Ronchetti Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M Rotondo INFN Laboratori Nazionali di Frascati, Frascati, Italy
S R Roy Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
M S Rudolph Syracuse University, Syracuse, New York, USA
T Ruf European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Ruiz Diaz Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
R A Ruiz Fernandez Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
J Ruiz Vidal Department of Physics and Astronomy, Uppsala University, Uppsala, Sweden (associated with School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom)
A Ryzhikov Affiliated with an institute covered by a cooperation agreement with CERN
J Ryzka AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
J J Saborido Silva Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
R Sadek Laboratoire Leprince-Ringuet, CNRS/IN2P3, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France
N Sagidova Affiliated with an institute covered by a cooperation agreement with CERN
N Sahoo University of Birmingham, Birmingham, United Kingdom
B Saitta INFN Sezione di Cagliari, Monserrato, Italy
M Salomoni INFN Sezione di Milano-Bicocca, Milano, Italy
C Sanchez Gras Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
I Sanderswood Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
R Santacesaria INFN Sezione di Roma La Sapienza, Roma, Italy
C Santamarina Rios Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
M Santimaria INFN Laboratori Nazionali di Frascati, Frascati, Italy
L Santoro Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
E Santovetti INFN Sezione di Roma Tor Vergata, Roma, Italy
A Saputi INFN Sezione di Ferrara, Ferrara, Italy European Organization for Nuclear Research (CERN), Geneva, Switzerland
D Saranin Affiliated with an institute covered by a cooperation agreement with CERN
G Sarpis School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M Sarpis Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
A Sarti INFN Sezione di Roma La Sapienza, Roma, Italy
C Satriano INFN Sezione di Roma La Sapienza, Roma, Italy
A Satta INFN Sezione di Roma Tor Vergata, Roma, Italy
M Saur School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
D Savrina Affiliated with an institute covered by a cooperation agreement with CERN
H Sazak Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
L G Scantlebury Smead Department of Physics, University of Oxford, Oxford, United Kingdom
A Scarabotto LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
S Schael I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
S Scherl Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
A M Schertz Eotvos Lorand University, Budapest, Hungary (associated with European Organization for Nuclear Research (CERN), Geneva, Switzerland)
M Schiller School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
H Schindler European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Schmelling Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany
B Schmidt European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Schmitt I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
H Schmitz Universität Bonn - Helmholtz-Institut für Strahlen und Kernphysik, Bonn, Germany (associated with Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany)
O Schneider Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
A Schopper European Organization for Nuclear Research (CERN), Geneva, Switzerland
N Schulte Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
S Schulte Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M H Schune Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
R Schwemmer European Organization for Nuclear Research (CERN), Geneva, Switzerland
G Schwering I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany
B Sciascia INFN Laboratori Nazionali di Frascati, Frascati, Italy
A Sciuccati European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Sellam Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
A Semennikov Affiliated with an institute covered by a cooperation agreement with CERN
M Senghi Soares Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
A Sergi INFN Sezione di Genova, Genova, Italy
N Serra European Organization for Nuclear Research (CERN), Geneva, Switzerland Physik-Institut, Universität Zürich, Zürich, Switzerland
L Sestini Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
A Seuthe Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
Y Shang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
D M Shangase University of Michigan, Ann Arbor, Michigan, USA (associated with Syracuse University, Syracuse, New York, USA)
M Shapkin Affiliated with an institute covered by a cooperation agreement with CERN
I Shchemerov Affiliated with an institute covered by a cooperation agreement with CERN
L Shchutska Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
T Shears Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
L Shekhtman Affiliated with an institute covered by a cooperation agreement with CERN
Z Shen School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
S Sheng Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
V Shevchenko Affiliated with an institute covered by a cooperation agreement with CERN
B Shi University of Chinese Academy of Sciences, Beijing, China
E B Shields INFN Sezione di Milano-Bicocca, Milano, Italy
Y Shimizu Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
E Shmanin Affiliated with an institute covered by a cooperation agreement with CERN
R Shorkin Affiliated with an institute covered by a cooperation agreement with CERN
J D Shupperd Syracuse University, Syracuse, New York, USA
R Silva Coutinho Syracuse University, Syracuse, New York, USA
G Simi Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
S Simone INFN Sezione di Bari, Bari, Italy
N Skidmore Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
R Skuza Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
T Skwarnicki Syracuse University, Syracuse, New York, USA
M W Slater University of Birmingham, Birmingham, United Kingdom
J C Smallwood Department of Physics, University of Oxford, Oxford, United Kingdom
E Smith Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
K Smith Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA
M Smith Imperial College London, London, United Kingdom
A Snoch Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
L Soares Lavra School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
M D Sokoloff University of Cincinnati, Cincinnati, Ohio, USA
F J P Soler School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A Solomin Affiliated with an institute covered by a cooperation agreement with CERN H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
A Solovev Affiliated with an institute covered by a cooperation agreement with CERN
I Solovyev Affiliated with an institute covered by a cooperation agreement with CERN
R Song School of Physics and Astronomy, Monash University, Melbourne, Australia
Y Song Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
Y Song Center for High Energy Physics, Tsinghua University, Beijing, China
Y S Song School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
F L Souza De Almeida Syracuse University, Syracuse, New York, USA
B Souza De Paula Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
E Spadaro Norella INFN Sezione di Milano, Milano, Italy
E Spedicato INFN Sezione di Bologna, Bologna, Italy
J G Speer Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
E Spiridenkov Affiliated with an institute covered by a cooperation agreement with CERN
P Spradlin School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
V Sriskaran European Organization for Nuclear Research (CERN), Geneva, Switzerland
F Stagni European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Stahl European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Stahl European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Stanislaus Department of Physics, University of Oxford, Oxford, United Kingdom
E N Stein European Organization for Nuclear Research (CERN), Geneva, Switzerland
O Steinkamp Physik-Institut, Universität Zürich, Zürich, Switzerland
O Stenyakin Affiliated with an institute covered by a cooperation agreement with CERN
H Stevens Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
D Strekalina Affiliated with an institute covered by a cooperation agreement with CERN
Y Su University of Chinese Academy of Sciences, Beijing, China
F Suljik Department of Physics, University of Oxford, Oxford, United Kingdom
J Sun INFN Sezione di Cagliari, Monserrato, Italy
L Sun School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
Y Sun University of Maryland, College Park, Maryland, USA
P N Swallow University of Birmingham, Birmingham, United Kingdom
K Swientek AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
F Swystun Department of Physics, University of Warwick, Coventry, United Kingdom
A Szabelski National Center for Nuclear Research (NCBJ), Warsaw, Poland
T Szumlak AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
M Szymanski European Organization for Nuclear Research (CERN), Geneva, Switzerland
Y Tan Center for High Energy Physics, Tsinghua University, Beijing, China
S Taneja Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
M D Tat Department of Physics, University of Oxford, Oxford, United Kingdom
A Terentev Physik-Institut, Universität Zürich, Zürich, Switzerland
F Terzuoli INFN Sezione di Pisa, Pisa, Italy
F Teubert European Organization for Nuclear Research (CERN), Geneva, Switzerland
E Thomas European Organization for Nuclear Research (CERN), Geneva, Switzerland
D J D Thompson University of Birmingham, Birmingham, United Kingdom
H Tilquin Imperial College London, London, United Kingdom
V Tisserand Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
S T'Jampens Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
M Tobin Institute Of High Energy Physics (IHEP), Beijing, China
L Tomassetti INFN Sezione di Ferrara, Ferrara, Italy
G Tonani INFN Sezione di Milano, Milano, Italy
X Tong School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
D Torres Machado Centro Brasileiro de Pesquisas Físicas (CBPF), Rio de Janeiro, Brazil
L Toscano Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
D Y Tou Center for High Energy Physics, Tsinghua University, Beijing, China
C Trippl DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
G Tuci Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
N Tuning Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
L H Uecker Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A Ukleja AGH - University of Science and Technology, Faculty of Physics and Applied Computer Science, Kraków, Poland
D J Unverzagt Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
E Ursov Affiliated with an institute covered by a cooperation agreement with CERN
A Usachov Nikhef National Institute for Subatomic Physics and VU University Amsterdam, Amsterdam, Netherlands
A Ustyuzhanin Affiliated with an institute covered by a cooperation agreement with CERN
U Uwer Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
V Vagnoni INFN Sezione di Bologna, Bologna, Italy
A Valassi European Organization for Nuclear Research (CERN), Geneva, Switzerland
G Valenti INFN Sezione di Bologna, Bologna, Italy
N Valls Canudas DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
H Van Hecke Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA
E van Herwijnen Imperial College London, London, United Kingdom
C B Van Hulse Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
R Van Laak Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M van Veghel Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands
R Vazquez Gomez ICCUB, Universitat de Barcelona, Barcelona, Spain
P Vazquez Regueiro Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
C Vázquez Sierra Instituto Galego de Física de Altas Enerxías (IGFAE), Universidade de Santiago de Compostela, Santiago de Compostela, Spain
S Vecchi INFN Sezione di Ferrara, Ferrara, Italy
J J Velthuis H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
M Veltri INFN Sezione di Firenze, Firenze, Italy
A Venkateswaran Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M Vesterinen Department of Physics, University of Warwick, Coventry, United Kingdom
D Vieira University of Cincinnati, Cincinnati, Ohio, USA
M Vieites Diaz European Organization for Nuclear Research (CERN), Geneva, Switzerland
X Vilasis-Cardona DS4DS, La Salle, Universitat Ramon Llull, Barcelona, Spain
E Vilella Figueras Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
A Villa INFN Sezione di Bologna, Bologna, Italy
P Vincent LPNHE, Sorbonne Université, Paris Diderot Sorbonne Paris Cité, CNRS/IN2P3, Paris, France
F C Volle Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
D Vom Bruch Aix Marseille Univ, CNRS/IN2P3, CPPM, Marseille, France
V Vorobyev Affiliated with an institute covered by a cooperation agreement with CERN
N Voropaev Affiliated with an institute covered by a cooperation agreement with CERN
K Vos Universiteit Maastricht, Maastricht, Netherlands (associated with Nikhef National Institute for Subatomic Physics, Amsterdam, Netherlands)
G Vouters Université Savoie Mont Blanc, CNRS, IN2P3-LAPP, Annecy, France
C Vrahas School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
J Walsh INFN Sezione di Pisa, Pisa, Italy
E J Walton School of Physics and Astronomy, Monash University, Melbourne, Australia
G Wan School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
C Wang Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
G Wang Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
J Wang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
J Wang Institute Of High Energy Physics (IHEP), Beijing, China
J Wang Center for High Energy Physics, Tsinghua University, Beijing, China
J Wang School of Physics and Technology, Wuhan University, Wuhan, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
M Wang INFN Sezione di Milano, Milano, Italy
N W Wang University of Chinese Academy of Sciences, Beijing, China
R Wang H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
X Wang Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
X W Wang Imperial College London, London, United Kingdom
Y Wang Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Z Wang Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
Z Wang Center for High Energy Physics, Tsinghua University, Beijing, China
Z Wang University of Chinese Academy of Sciences, Beijing, China
J A Ward School of Physics and Astronomy, Monash University, Melbourne, Australia Department of Physics, University of Warwick, Coventry, United Kingdom
N K Watson University of Birmingham, Birmingham, United Kingdom
D Websdale Imperial College London, London, United Kingdom
Y Wei School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
B D C Westhenry H.H. Wills Physics Laboratory, University of Bristol, Bristol, United Kingdom
D J White Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
M Whitehead School of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom
A R Wiederhold Department of Physics, University of Warwick, Coventry, United Kingdom
D Wiedner Fakultät Physik, Technische Universität Dortmund, Dortmund, Germany
G Wilkinson Department of Physics, University of Oxford, Oxford, United Kingdom
M K Wilkinson University of Cincinnati, Cincinnati, Ohio, USA
M Williams Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
M R J Williams School of Physics and Astronomy, University of Edinburgh, Edinburgh, United Kingdom
R Williams Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
F F Wilson STFC Rutherford Appleton Laboratory, Didcot, United Kingdom
W Wislicki National Center for Nuclear Research (NCBJ), Warsaw, Poland
M Witek Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
L Witola Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
C P Wong Los Alamos National Laboratory (LANL), Los Alamos, New Mexico, USA
G Wormser Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
S A Wotton Cavendish Laboratory, University of Cambridge, Cambridge, United Kingdom
H Wu Syracuse University, Syracuse, New York, USA
J Wu Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Y Wu School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
K Wyllie European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Xian Guangdong Provincial Key Laboratory of Nuclear Science, Guangdong-Hong Kong Joint Laboratory of Quantum Matter, Institute of Quantum Matter, South China Normal University, Guangzhou, China (associated with Center for High Energy Physics, Tsinghua University, Beijing, China)
Z Xiang Institute Of High Energy Physics (IHEP), Beijing, China
Y Xie Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
A Xu INFN Sezione di Pisa, Pisa, Italy
J Xu University of Chinese Academy of Sciences, Beijing, China
L Xu Center for High Energy Physics, Tsinghua University, Beijing, China
L Xu Center for High Energy Physics, Tsinghua University, Beijing, China
M Xu Department of Physics, University of Warwick, Coventry, United Kingdom
Z Xu Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
Z Xu University of Chinese Academy of Sciences, Beijing, China
Z Xu Institute Of High Energy Physics (IHEP), Beijing, China
D Yang Center for High Energy Physics, Tsinghua University, Beijing, China
S Yang University of Chinese Academy of Sciences, Beijing, China
X Yang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
Y Yang INFN Sezione di Genova, Genova, Italy
Z Yang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
Z Yang University of Maryland, College Park, Maryland, USA
V Yeroshenko Université Paris-Saclay, CNRS/IN2P3, IJCLab, Orsay, France
H Yeung Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom
H Yin Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
C Y Yu School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
J Yu School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
X Yuan Institute Of High Energy Physics (IHEP), Beijing, China
E Zaffaroni Institute of Physics, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
M Zavertyaev Max-Planck-Institut für Kernphysik (MPIK), Heidelberg, Germany
M Zdybal Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland
M Zeng Center for High Energy Physics, Tsinghua University, Beijing, China
C Zhang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
D Zhang Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
J Zhang University of Chinese Academy of Sciences, Beijing, China
L Zhang Center for High Energy Physics, Tsinghua University, Beijing, China
S Zhang School of Physics and Electronics, Hunan University, Changsha City, China (associated with Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China)
S Zhang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
Y Zhang School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
Y Zhang Department of Physics, University of Oxford, Oxford, United Kingdom
Y Z Zhang Center for High Energy Physics, Tsinghua University, Beijing, China
Y Zhao Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A Zharkova Affiliated with an institute covered by a cooperation agreement with CERN
A Zhelezov Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
X Z Zheng Center for High Energy Physics, Tsinghua University, Beijing, China
Y Zheng University of Chinese Academy of Sciences, Beijing, China
T Zhou School of Physics State Key Laboratory of Nuclear Physics and Technology, Peking University, Beijing, China
X Zhou Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Y Zhou University of Chinese Academy of Sciences, Beijing, China
V Zhovkovska Department of Physics, University of Warwick, Coventry, United Kingdom
L Z Zhu University of Chinese Academy of Sciences, Beijing, China
X Zhu Center for High Energy Physics, Tsinghua University, Beijing, China
X Zhu Institute of Particle Physics, Central China Normal University, Wuhan, Hubei, China
Z Zhu University of Chinese Academy of Sciences, Beijing, China
V Zhukov I. Physikalisches Institut, RWTH Aachen University, Aachen, Germany Affiliated with an institute covered by a cooperation agreement with CERN
J Zhuo Instituto de Fisica Corpuscular, Centro Mixto Universidad de Valencia - CSIC, Valencia, Spain
Q Zou Institute Of High Energy Physics (IHEP), Beijing, China University of Chinese Academy of Sciences, Beijing, China
D Zuliani Università degli Studi di Padova, Università e INFN, Padova, Padova, Italy
G Zunica Department of Physics and Astronomy, University of Manchester, Manchester, United Kingdom

Collapse

Occupational daily walking steps have inverse relationship with papillary thyroid cancer risk and progression: a retrospective analysis

OBJECTIVES

Investigate the impact of daily occupational walking steps on the progression of papillary thyroid cancer (PTC), a topic hitherto underresearched.

MATERIAL AND METHODS

The authors analyzed the data from 800 individuals with PTC across stages 0-IV. Participants were evenly divided into 2 distinct occupational groups: office workers and construction workers (N = 400 each). Data included comprehensive records of daily walking steps, demographic information, and clinical indicators. Pearson's correlation coefficients or analysis of variance (ANOVA) were employed to assess the linkage between daily walking steps and PTC risk and stage, as well as associated biochemical markers.

RESULTS

The analysis revealed a significant inverse relationship between daily walking steps and PTC risk. A higher frequency of daily steps was associated with reduced chances of PTC onset and a lower diagnostic stage of the disease. This protective effect of physical activity was particularly pronounced in the construc- tion worker cohort. Subsequent evaluations showed that construction workers who consistently logged higher daily steps had markedly lower levels of thyroid-stimulating hormone (TSH), free triiodothyronine, free thyroxine, thyroid peroxidase antibody, thyroglobulin antibody, and thy- roglobulin (Tg). Notably, daily walking steps exhibited a strong inverse correlation with body mass index (BMI), age, PTC volumes, and levels of TSH and Tg across both occupational groups (ρ < -0.37). The increase in daily steps was associated with the reduction in PTC stages (p < 0.001).

CONCLUSIONS

The research underscores the potential benefits of increased daily walking steps, suggesting that they may play a protective role in reducing PTC risk and moderating its progression. Int J Occup Med Environ Health. 2024;37(1):58-71.

Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study

BACKGROUND & AIMS

In phase 2 studies, efruxifermin, an Fc-FGF21 analog, significantly reduced steatohepatitis and fibrosis in patients with non-alcoholic steatohepatitis, now called metabolic dysfunction-associated steatohepatitis (MASH), for which there is no approved treatment. Type 2 diabetes (T2D) and obesity are prevalent among patients with MASH and increasingly treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs). This study evaluated the safety and efficacy of efruxifermin in patients with MASH, fibrosis, and T2D taking a GLP-1RA.

METHODS

Cohort D was a double-blind, placebo-controlled, phase 2b study in adults with T2D and MASH with fibrosis (F1-F3) on stable GLP-1RA therapy randomized (2:1) to receive efruxifermin 50 mg or placebo, once weekly for 12 weeks. The primary endpoint was safety and tolerability of efruxifermin added to a stable dose of GLP-1RA. Secondary endpoints included changes in hepatic fat fraction (HFF), markers of liver injury and fibrosis, and metabolic parameters.

RESULTS

Adults (N = 31) with T2D and MASH fibrosis (F1-F3) on a stable GLP-1RA (semaglutide, 48.4%; dulaglutide, 45.2%; liraglutide, 6.5%) received efruxifermin 50 mg (n = 21) or placebo (n = 10) for 12 weeks. The addition of efruxifermin to a GLP-1RA appeared safe and well-tolerated. The most frequent efruxifermin-related adverse events were mild to moderate gastrointestinal events. One patient receiving efruxifermin discontinued due to nausea, and another withdrew consent. There were no treatment-related serious adverse events. After 12 weeks, efruxifermin reduced HFF by 65% (P < .0001 vs placebo) compared with a 10% reduction for placebo (GLP-1RA alone). Efruxifermin also improved noninvasive markers of liver injury, fibrosis, glucose, and lipid metabolism while maintaining GLP-1RA-mediated weight loss.

CONCLUSIONS

The tolerability profile of efruxifermin added to GLP-1RA appeared comparable to that of either drug alone, while also significantly reducing HFF and noninvasive markers of fibrosis in patients with MASH and T2D. Liver health in patients already on a GLP-1RA may be further improved by addition of efruxifermin.

CLINICALTRIALS

gov, Number: NCT05039450.

FHL2 promotes the aggressiveness of lung adenocarcinoma by inhibiting autophagy via activation of the PI3K/AKT/mTOR pathway

BACKGROUND

Increasing evidence indicates that four and a half LIM domains 2 (FHL2) plays a crucial role in the progression of various cancers. However, the biological functions and molecular mechanism of FHL2 in lung adenocarcinoma (LUAD) remain unclear.

METHODS

We evaluated the prognostic value of FHL2 in LUAD using public datasets and further confirmed its prognostic value with our clinical data. The biological functions of FHL2 in LUAD were evaluated by in vitro and in vivo experiments. Pathway analysis and rescue experiments were subsequently performed to explore the molecular mechanism by which FHL2 promoted the progression of LUAD.

RESULTS

FHL2 was upregulated in LUAD tissues compared to adjacent normal lung tissues, and FHL2 overexpression was correlated with unfavorable outcomes in patients with LUAD. FHL2 knockdown significantly suppressed the proliferation, migration and invasion of LUAD cells, while FHL2 overexpression had the opposite effect. Mechanistically, FHL2 upregulated the PI3K/AKT/mTOR pathway and subsequently inhibited autophagy in LUAD cells. The effects FHL2 on the proliferation, migration and invasion of LUAD cells are dependent on the inhibition of autophagy, as of induction autophagy attenuated the aggressive phenotype induced by FHL2 overexpression.

CONCLUSIONS

FHL2 promotes the progression of LUAD by activating the PI3K/AKT/mTOR pathway and subsequently inhibiting autophagy, which can be exploited as a potential therapeutic target for LUAD.

Relationship between hemoglobin and lung cancer: evidence from Mendelian randomization and National Health and Nutrition Examination Survey

BACKGROUND

Lung cancer is the primary cause of cancer-related mortality worldwide. Hemoglobin (Hb) represents the most widely utilized test parameter in clinical settings. However, few articles have examined the causal relationship between Hb concentration and lung cancer incidence.

METHODS

Mendelian randomization (MR) was first conducted to investigate the potential causality between Hb and lung cancer. Sensitivity analyses were applied to validate the reliability of MR results. Then, the National Health and Nutrition Examination Survey (NHANES) database was used to verify the effect of Hb on the prognosis of lung cancer.

RESULTS

The MR analysis demonstrated that Hb was casually associated with the decreased risk of lung cancer in the European population (ORIVW 0.84, 95% CI 0.75-0.95, p = 0.006; ORWeighted-median 0.78, 95% CI 0.65-0.94, p = 0.008; ORMR-Egger 0.82, 95% CI 0.64-1.04, p = 0.11). The results from the NHANES database showed that a high value of Hb was associated with better outcomes for patients with lung cancer (HR 0.45, 95% CI 0.26-0.79, p = 1.6E-03).

CONCLUSIONS

Our study provides further evidence for the relationship between Hb levels and lung cancer, highlighting the potential significance of Hb as a biomarker for predicting the risk and prognosis of lung cancer.

N-Heterocycle Modified Graphene Quantum Dots as Topoisomerase Targeted Nanoantibiotics for Combating Microbial Infections

Developing next-generation antibiotics to eliminate multidrug-resistant (MDR) bacteria/fungi and stubborn biofilms is challenging, because of the excessive use of currently available antibiotics. Herein, the fabrication of anti-infection graphene quantum dots (GQDs) is reported, as a new class of topoisomerase (Topo) targeting nanoantibiotics, by modification of rich N-heterocycles (pyridinic N) at edge sites. The membrane-penetrating, nucleus-localizing, DNA-binding GQDs not only damage the cell walls/membranes of bacteria or fungi, but also inhibit DNA-binding proteins, such as Topo I, thereby affecting DNA replication, transcription, and recombination. The obtained GQDs exhibit excellent broad-spectrum antimicrobial activity against non-MDR bacteria, MDR bacteria, endospores, and fungi. Beyond combating planktonic microorganisms, GQDs inhibit the formation of biofilms and can kill live bacteria inside biofilms. RNA-seq further demonstrates the upregulation of riboflavin biosynthesis genes, DNA repair related genes, and transport proteins related genes in methicillin-resistant S. aureus (MRSA) in response to the stress induced by GQDs. In vivo animal experiments indicate that the biocompatible GQDs promote wound healing in MRSA or C. albicans-infected skin wound models. Thus, GQDs may be a promising antibacterial and antifungal candidate for clinical applications in treating infected wounds and eliminating already-formed biofilms.

Inhibitory interaction of flavonoids with organic anion transporter 3 and their structure-activity relationships for predicting nephroprotective effects

The organic anion transporter 3 (OAT3), an important renal uptake transporter, is associated with drug-induced acute kidney injury (AKI). Screening and identifying potent OAT3 inhibitors with little toxicity in natural products, especially flavonoids, in reducing OAT3-mediated AKI is of great value. The five strongest OAT3 inhibitors from the 97 flavonoids markedly decreased aristolochic acid I-induced cytotoxicity and alleviated methotrexate-induced nephrotoxicity. The pharmacophore model clarified hydrogen bond acceptors and hydrophobic groups are the critical pharmacophores. These findings would provide valuable information in predicting the potential risks of flavonoid-containing food/herb-drug interactions and optimizing flavonoid structure to alleviate OAT3-related AKI.

Intratumoral CXCR4hi neutrophils display ferroptotic and immunosuppressive signatures in hepatoblastoma

Pediatric hepatoblastoma (HB) is the most common primary liver malignancy in infants and children. With great diversity and plasticity, tumor-infiltrating neutrophils were one of the most determining factors for poor prognosis in many malignant tumors. In this study, through bulk RNA sequencing for sorted blood and tumor-infiltrated neutrophils and comparison of neutrophils in tumor and para-tumor tissue by single-cell sequencing, we found that intratumoral neutrophils were composed of heterogenous functional populations at different development stages. Our study showed that terminally differentiated neutrophils with active ferroptosis prevailed in tumor tissue, whereas, in para-tumor, pre-fate naïve neutrophils were dominant and ferroptotic neutrophils dispersed in a broad spectrum of cell maturation. Gene profiling and in vitro T-cell coculture experiment confirmed that one of main functional intratumoral neutrophils was mainly immunosuppressive, which relied on the activation of ferroptosis. Combining the bulk RNA-seq, scRNA-seq data, and immunochemistry staining of tumor samples, CXCL12/CXCR4 chemotaxis pathway was suggested to mediate the migration of neutrophils in tumors as CXCR4 highly expressed by intratumoral neutrophils and its ligand CXCL12 expressed much higher level in tumor than that in para-tumor. Moreover, our study pinpointed that infiltrated CXCR4hi neutrophils, regardless of their differential distribution of cell maturation status in HB tumor and para-tumor regions, were the genuine perpetrators for immune suppression. Our data characterized the ferroptosis-dependent immunosuppression energized by intratumoral CXCR4 expression neutrophils and suggest a potential cell target for cancer immunotherapies.

Clinical features, treatment strategies, and prognosis of epithelioid inflammatory myofibroblastic sarcoma in children: a multicenter experience

Background

Inflammatory myofibroblastic tumors (IMTs) are a spectrum of tumors that range in morphology and biological behavior from benign, intermediate, to apparently malignant and epithelioid inflammatory myofibroblastic sarcoma (EIMS) is one of the malignant subtypes. This study tried to provide experience and new ideas for treating this rare disease.

Methods

This study retrospectively analyzed and followed up 12 children with EIMS admitted to Beijing Children's Hospital, Baoding Children's Hospital, and Children's Hospital of Chongqing Medical University from August 2016 to May 2022.

Results

Of the 12 children, 7 were male and 5 were female, with a median age of 74.50 [interquartile range (IQR), 61.50-90.00] months. Of these patients, eight had a single lesion and four had multiple lesions. The maximum diameter of the single tumor foci was 19.30 cm, the full meridian of the multiple tumor foci target lesions was 32.67 cm, and the median maximum tumor size was 11.99 (IQR, 7.80-15.70) cm. The site of disease was the abdominopelvic cavity in eight cases, the thoracic cavity in two cases, the maxillofacial region in one case, and the larynx in one case. The clinical manifestations were predominantly elevated body temperature (n=8). There was one case of ROS1 fusion mutation and nine cases of ALK fusion mutation. Of the 12 children, 6 were biopsied at the initial diagnosis and 6 were surgically treated. Follow-up treatment included preoperative neoadjuvant chemotherapy (n=4), peritoneal thermal perfusion therapy (n=2), targeted therapy (n=3), postoperative chemotherapy (n=5), and radiotherapy (n=3). The follow-up time was 14.50 (IQR, 10.50-31.50) months, with eight cases of tumor-free survival, two cases of death, and two cases of loss of follow-up.

Conclusions

EIMS in children is extremely rare and clinically aggressive. The clinical presentation is nonspecific, and the initial diagnosis of the tumor is often large. Mutations in the ALK gene are common in EIMS. Surgery is the mainstay of EIMS treatment, and patients benefit from a multidisciplinary combination that includes targeted therapies, with long-term prognosis remaining subject to ongoing follow-up.

The structure-activity relationship of copper hydride nanoclusters in hydrogenation and reduction reactions

Copper hydrides are highly active catalysts in hydrogenation reactions and reduction processes. Three Stryker-type copper hydride nanoclusters (NCs), [(TPP)CuH]6, [(TCP)CuH]6 and [(TOP)CuH]6 (TPP = triphenylphosphine, TCP = tricyclohexylphosphine and TOP = tri-n-octylphosphine), were synthesized in this study. Due to variations in the electron-donating properties of the phosphine ligands, the UV-visible absorption spectra of the three NCs exhibited notable distinctions. The influence of the phosphine ligands on the effectiveness of the NCs as hydride sources in hydrogenation processes, as well as on the applicability as homogeneous catalysts for reduction reactions, was systematically studied. Due to the highest electron-donating properties of the TOP ligand, [(TOP)CuH]6 was found to exhibit superior performance in both hydrogenation reactions and catalytic reduction reactions. Moreover, these hydrophobic NCs worked well as heterogeneous catalysts in the reduction of 4-nitrophenol.

Observation of Cabibbo-Suppressed Two-Body Hadronic Decays and Precision Mass Measurement of the Ω_{c}^{0} Baryon

The first observation of the singly Cabibbo-suppressed Ω_{c}^{0}→Ω^{-}K^{+} and Ω_{c}^{0}→Ξ^{-}π^{+} decays is reported, using proton-proton collision data at a center-of-mass energy of 13 TeV, corresponding to an integrated luminosity of 5.4  fb^{-1}, collected with the LHCb detector between 2016 and 2018. The branching fraction ratios are measured to be B(Ω_{c}^{0}→Ω^{-}K^{+})/B(Ω_{c}^{0}→Ω^{-}π^{+})=[6.08±0.51(stat)±0.40(syst)]%,B(Ω_{c}^{0}→Ξ^{-}π^{+})/B(Ω_{c}^{0}→Ω^{-}π^{+})=[15.81±0.87(stat)±0.44(syst)±0.16(ext)]%. In addition, using the Ω_{c}^{0}→Ω^{-}π^{+} decay channel, the Ω_{c}^{0} baryon mass is measured to be M(Ω_{c}^{0})=2695.28±0.07(stat)±0.27(syst)±0.30(ext)  MeV, improving the precision of the previous world average by a factor of 4.

Enhanced Production of Λ_{b}^{0} Baryons in High-Multiplicity pp Collisions at sqrt[s]=13 TeV

The production rate of Λ_{b}^{0} baryons relative to B^{0} mesons in pp collisions at a center-of-mass energy sqrt[s]=13  TeV is measured by the LHCb experiment. The ratio of Λ_{b}^{0} to B^{0} production cross sections shows a significant dependence on both the transverse momentum and the measured charged-particle multiplicity. At low multiplicity, the ratio measured at LHCb is consistent with the value measured in e^{+}e^{-} collisions, and increases by a factor of ∼2 with increasing multiplicity. At relatively low transverse momentum, the ratio of Λ_{b}^{0} to B^{0} cross sections is higher than what is measured in e^{+}e^{-} collisions, but converges with the e^{+}e^{-} ratio as the momentum increases. These results imply that the evolution of heavy b quarks into final-state hadrons is influenced by the density of the hadronic environment produced in the collision. Comparisons with several models and implications for the mechanisms enforcing quark confinement are discussed.

Comparing the mechanisms of syntrophic volatile fatty acids oxidation and methanogenesis recovery from ammonia stress in regular and biochar-assisted anaerobic digestion: Different roads lead to the same goal

Biochar has been recognized as a promising additive to mitigate ammonia inhibition during syntrophic methanogenesis, while the key function of biochar in this process is still in debates. This study clarified the distinct mechanisms of syntrophic volatile fatty acids -oxidizing and methanogenesis recovery from ammonia inhibition in regular and biochar-assisted anaerobic digestion. Under 5 g/L ammonia stress, adding biochar shortened the methanogenic lag time by 10.9% and dramatically accelerated the maximum methane production rate from 60.3 to 94.7 mLCH4/gVSsludge/d. A photometric analysis with a nano-WO3 probe revealed that biochar enhanced the extracellular electron transfer (EET) capacity of suspended microbes (Pearson's r = -0.98), confirming that biochar facilitated methanogenesis by boosting EET between syntrophic butyrate oxidizer and methanogens. Same linear relationship between EET capacity and methanogenic rate was not observed in the control group. Microbial community integrating functional genes prediction analysis uncovered that biochar re-shaped syntrophic partners by enriching Constridium_sensu_stricto/Syntrophomonas and Methanosarcina. The functional genes encoding Co-enzyme F420 hydrogenase and formylmethanofuran dehydrogenase were upregulated by 1.4-2.3 times, consequently enhanced the CO2-reduction methanogenesis pathway. Meanwhile, the abundances of gene encoding methylene-tetrahydrofolate transformation, a series of intermediate processes involved in acetate oxidation, in the biochar-assisted group were 28.2-63.7% higher than these in control group. Comparatively, Methanosaeta played a pivotal role driving aceticlastic methanogenesis in the control group because the abundance of gene encoding acetyl-CoA decarbonylase/synthase complex increased by 1.9 times, suggesting an aceticlastic combining H2-based syntrophic methanogenesis pathway was established in control group to resist ammonia stress. A 2nd period experiment elucidated that although depending on distinct mechanisms, the volatile fatty acid oxidizers and methanogens in both groups developed sustained and stable strategies to resist ammonia stress. These findings provided new insights to understand the distinct methanogenic recovery strategy to resist toxic stress under varied environmental conditions.

[Retrospective study of 70 cases with the head and neck non-parameningeal rhabdomyosarcoma]

Objective: To analyze the treatment outcomes and prognoses of children with head and neck non-parameningeal rhabdomyosarcoma (HNnPM RMS). Methods: A retrospective analysis was performed on the clinical data of children with HNnPM RMS admitted to Beijing Children's Hospital from September 2012 to September 2022. The clinical features, comprehensive treatment modes and prognoses of the patients were analyzed. The overall survival rate (OS) and event free survival rate (EFS) were calculated using the Kaplan-Meier method, and univariate analysis was performed using the Log-rank test. Results: A total of 70 children were included in this study, 38 males and 32 females, with a median age of 47 months (2-210 months). Pathological subtypes including the embryonal in 27 cases, the alveolar in 36 cases and the spindle cell and sclerosing in 7 cases. Thirty children (83.3%) with alveolar type were positive for FOXO1 gene fusion. All 70 children underwent chemotherapy, including 38 with neoadjuvant chemotherapy and 32 with adjuvant chemotherapy. Sixty of 70 children underwent surgery, of whom, 10 underwent two or more surgeries. There were 63 children underwent radiotherapy, including 54 with intensity-modulated radiation therapy, 4 with particle implantation and 5 with proton therapy. The median follow-up was 45 (5-113) months, the 5-year OS was 73.2%, and the 5-year EFS was 57.7%. Univariate analysis showed lymph node metastasis (χ2=5.022, P=0.025), distant metastasis (χ2=8.258, P=0.004), and high Intergroup Rhabdomyosarcoma Study (IRS) group (χ2=9.859, P=0.029) as risk factors for poor prognosis. Before June 2016, the 5-year OS based on BCH-RMS-2006 scheme was 63.6%, and after 2016, the 5-year OS based on CCCG-RMS-2016 scheme was 79.6%. Conclusion: Multidisciplinary combined standardized treatment can offer good treatment outcome and prognosis for children with HNnPM RMS. Local control is a key to the efficacy of comprehensive treatment.

Quantifying the roles of thermal volatilization and decomposition in microwave remediation of polycyclic aromatic hydrocarbon-polluted soil and modeling remediation effectiveness

Microwave irradiation is a promising technology for the remediation of soil contaminated by organic contaminants. However, the roles of volatilization and decomposition in microwave removal of polycyclic aromatic hydrocarbons (PAHs) in soil have not yet been quantitatively determined. A model describing the removal efficiency of benz(a)anthracene (BaA) at different treatment times and varied conditions was constructed, wherein BaA removal efficiency was positively and linearly correlated with soil temperature. BaA removal in soil was attributed to thermal volatilization (97.8%) and decomposition (2.2%). Radicals such as ∙OH and ∙O 2- were found to initiate BaA decomposition, the pathway of which was elucidated through HPLC-MS analysis, revealing benz(a)anthracene-7,12-dione as the main intermediate product. The new ideas and perspectives founded in this study offer theoretical support for microwave remediation of organic compound-contaminated sites.

Improved Measurement of CP Violation Parameters in B_{s}^{0}→J/ψK^{+}K^{-} Decays in the Vicinity of the ϕ(1020) Resonance

The decay-time-dependent CP asymmetry in B_{s}^{0}→J/ψ(→μ^{+}μ^{-})K^{+}K^{-} decays is measured using proton-proton collision data, corresponding to an integrated luminosity of 6  fb^{-1}, collected with the LHCb detector at a center-of-mass energy of 13 TeV. Using a sample of approximately 349 000 B_{s}^{0} signal decays with an invariant K^{+}K^{-} mass in the vicinity of the ϕ(1020) resonance, the CP-violating phase ϕ_{s} is measured, along with the difference in decay widths of the light and heavy mass eigenstates of the B_{s}^{0}-B[over ¯]_{s}^{0} system, ΔΓ_{s}, and the difference of the average B_{s}^{0} and B^{0} meson decay widths, Γ_{s}-Γ_{d}. The values obtained are ϕ_{s}=-0.039±0.022±0.006  rad, ΔΓ_{s}=0.0845±0.0044±0.0024  ps^{-1}, and Γ_{s}-Γ_{d}=-0.0056_{-0.0015}^{+0.0013}±0.0014  ps^{-1}, where the first uncertainty is statistical and the second systematic. These are the most precise single measurements to date and are consistent with expectations based on the Standard Model and with the previous LHCb analyses of this decay. These results are combined with previous independent LHCb measurements. The phase ϕ_{s} is also measured independently for each polarization state of the K^{+}K^{-} system and shows no evidence for polarization dependence.

Predictive Value of Quantitative Electroencephalogram Combined with Transcranial Doppler Ultrasound in Delayed Cerebral Ischemia after Subarachnoid Hemorrhage

OBJECTIVE

To explore the predictive value of transcranial Doppler ultrasound (TCD) combined with quantitative electroencephalogram (QEEG) in delayed cerebral ischemia (DCI) caused by aneurysmal subarachnoid hemorrhage (aSAH).

METHODS

The participants were 105 patients with aSAH treated from June 2020 to December 2022. Patients were divided into DCI group (n = 34) and non-DCI group (n = 71) according to the presence of DCI 14 days after onset. Further comparison was conducted on the baseline data as well as the parameters of QEEG and TCD within 24 hours after admission. Multivariate logistic analysis was performed to investigate risk factors related to DCI within 14 days of admission in aSAH patients.

RESULTS

There were significant differences in the comparison of the proportion of Hunt-Hess grading, relative δ power (RDP), relative α power (RAP), relative α/β power ratio (ADR), as well as peak systolic velocity (Vs), mean blood flow velocity (MBFV) and pulsatility index (PI) of middle cerebral artery between the two groups (P < 0.05). Furthermore, Logistic regression analysis revealed that ADR (odds ratio 1.668, 95% CI 1.369-4.345) and MBFV of middle cerebral artery (odds ratio 3.279, 95% CI 2.332-6.720) were risk factors for the occurrence of DCI in aSAH patients (P < 0.05). In addition, evaluation of the predictive value revealed that combined use of the 2 indicators showed the highest predictive value (area under the curve 0.959, 95% CI 0.896-0.993).

CONCLUSIONS

Patients with aSAH complicated by DCI have relatively higher MBFV of middle cerebral artery and ADR. Combined use of the 2 indicators can provide reference for early prediction of DCI in aSAH patients.

Cyclometalated iridium(III) complexes as anti-breast cancer and anti-metastasis agents via STAT3 inhibition

Breast cancer is the most commonly diagnosed cancer and second‑leading cause of cancer deaths in women. Signal transducer and activator of transcription 3 (STAT3) plays a critical role in promoting breast cancer cell proliferation, invasion, angiogenesis, and metastasis, and the high expression of STAT3 is related to the occurrence and poor chemotherapy sensitivity of breast cancer. Iridium(III) complexes Ir-PTS-1- 4 containing a pterostilbene-derived ligand were synthesized to inhibit the STAT3 pathway in breast cancer. Ir-PTS-4 inhibited the proliferation of breast cancer cells by suppressing the expression of phosphorylated STAT3 and STAT3-related cyclin D1, arresting cell cycle in the S-phase, inducing DNA damage and reactive oxygen species (ROS) generation, eventually leading to autophagic cell death. The cell metastasis and invasion were also inhibited after Ir-PTS-4 treatment. Besides, Ir-PTS-4 exhibited excellent anti-proliferation activity in 3D multicellular tumor spheroids, showing potential for the treatment of solid tumors. This work presents the rational design of metal-based anticancer agents to block the STAT3 pathway for simultaneously inhibiting breast cancer proliferation and metastasis.

LH on GnRH-ant day to basal LH affects the IVF/ICSI outcome of PCOS women undergoing GnRH-antagonist protocol

OBJECTIVE

The aim of this study was to investigate the influence of ratio of serum luteinizing hormone (LH) on gonadotropin-releasing hormone antagonist (GnRH-ant) day to basal LH (hLH/bLH) on in-vitro fertilization or intracytoplasmic sperm injection (IVF/ICSI) outcome in polycystic ovary syndrome (PCOS) women who received GnRH-ant protocol for controlled ovarian hyperstimulation (COH).

METHODS

This retrospective study was conducted in women with PCOS (n = 1116) who underwent the GnRH-ant protocol for COH between 2015 and 2022 and were stratified as group A (hLH/bLH < 1, n = 489) and group B (hLH/bLH ≥ 1, n = 627) according to the variation of serum LH. The outcomes of COH and the first frozen embryo transfer (FET) cycle were compared between group A, B and the linear relationship between hLH/bLH ratio and IVF/ICSI outcomes were studied by multivariate linear regression analysis and restricted cubic spline (RCS) models.

RESULTS

There were significant differences in baseline characteristics and outcomes between group A and B. Group A had higher levels of bLH, AMH, estradiol (E2) on GnRH-ant start day and lower levels of LH on GnRH-ant start day. Group B has better ovulation induction outcomes: more retrieved oocytes, normally fertilized oocytes (2PN), cleavage embryos, available embryos and high-quality blastocysts. Multivariate linear regression analysis found no statistically significant connection between hLH/bLH and clinical outcomes. RCS models showed hLH/bLH had nonlinear association with outcomes, including number of oocytes retrieved, 2PN, available embryos, incidence of OHSS, chemical pregnancy, clinical pregnancy, abortion and live birth.

CONCLUSIONS

hLH/bLH ratio could be a more forward-looking indicator of clinical outcome in women with PCOS undergoing GnRH-ant protocols than LH on trigger day and the ratio of LH level on trigger day to basal LH. hLH/bLH = 1 may be the best condition for higher live birth rate and lower OHSS rate.

Lipid mediators obtained from docosahexaenoic acid by soybean lipoxygenase attenuate RANKL-induced osteoclast differentiation and rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic immune-mediated inflammatory disease characterized by persistent inflammation and joint destruction. A lipid mediator (LM, namely, 17S-monohydroxy docosahexaenoic acid, resolvin D5, and protectin DX in a ratio of 3:47:50) produced by soybean lipoxygenase from DHA, exhibits anti-inflammatory activity. In this study, we determined the effect of LM on collagen antibody-induced arthritis (CAIA) in mice and receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation in RAW264.7 cells. LM effectively downregulated the expression of tartrate-resistant acid phosphatase (TRAP) and cathepsin K, inhibited osteoclast formation, and suppressed the NF-κB signaling pathway in vitro. In vivo, LM at 10 μg/kg/day significantly decreased paw swelling and inhibited progression of arthritis in CAIA mice. Moreover, proinflammatory cytokine (tumor necrosis factor-α, interleukin (IL)-6, IL-1β, IL-17, and interferon-γ) levels in serum were decreased, whereas IL-10 levels were increased following LM treatment. Furthermore, LM alleviated joint inflammation, cartilage erosion, and bone destruction in the ankles, which may be related to matrix metalloproteinase and Janus kinase (JAK)-signal transducer and activators of transcription (STAT) signaling pathway. Our findings suggest that LM attenuates arthritis severity, restores serum imbalances, and modifies joint damage. Thus, LM represents a promising therapy for relieving RA symptoms.

Pediatric spindle cell/sclerosing rhabdomyosarcoma with FUS-TFCP2 fusion: a case report and literature review

Background

FUS-TFCP2 gene fusion is a recently identified and highly distinct molecular subtype of spindle cell/sclerosing rhabdomyosarcoma (RMS), with fewer than 40 cases being reported to date. Due to its low incidence, clinical studies on this subtype are limited. Here, we report a new case of this rare entity to describe and summarize its unique clinical characteristics and treatment process, aiming to emphasize the importance of molecular testing for spindle cell/sclerosing RMS and increase the understanding of this subtype. By summarizing and comparing with previous reports on RMS with the EWSR1/FUS-TFCP2 fusion mutation, we hope to make some new hints for its management.

Case Description

In this report, we describe a rare case of spindle cell/sclerosing RMS in a 13-year-old boy, who had a massive destructive lesion involving the mandible. Next-generation sequencing of tumor tissue revealing a FUS-TFCP2 fusion. The tumor was extremely aggressive and showed resistance to polychemotherapy, after 4 cycles of multi drug combined chemotherapy, the primary tumor still continued to grow, and suspicious chest metastasis occurred. Even after aggressive total resection of the primary tumor and postoperative chemotherapy, systemic metastasis to the vertebra and chest could not be prevented yet, ultimately with a fatal outcome within 6 months. We additionally summarize 37 cases of RMS with the EWSR1/FUS-TFCP2 fusion mutation reported in the literature. This subtype was found to be almost exclusively primary in bone and histologically showed a common origin of epithelium and muscle. The high aggressiveness made the conventional standard chemoradiotherapy ineffective. Because most tumors of this subtype express ALK protein, ALK inhibitors seem to be a new target for its therapy.

Conclusions

Spindle cell/sclerosing RMS with FUS-TFCP2 fusion has its unique clinical characteristics and progression. It shows a marked skeletal predilection and an aggressive clinical course, typically resistant to traditional standard treatments for RMS. Therefore, molecular detection is crucial in managing this subtype. Once the diagnosis is clear, a more aggressive treatment plan is needed. In addition, almost all cases were found to have a positive expression of ALK. So ALK inhibitors can be a choice of targeted therapy.

D-ribose metabolic disorder and diabetes mellitus

D-ribose, an ubiquitous pentose compound found in all living cells, serves as a vital constituent of numerous essential biomolecules, including RNA, nucleotides, and riboflavin. It plays a crucial role in various fundamental life processes. Within the cellular milieu, exogenously supplied D-ribose can undergo phosphorylation to yield ribose-5-phosphate (R-5-P). This R-5-P compound serves a dual purpose: it not only contributes to adenosine triphosphate (ATP) production through the nonoxidative phase of the pentose phosphate pathway (PPP) but also participates in nucleotide synthesis. Consequently, D-ribose is employed both as a therapeutic agent for enhancing cardiac function in heart failure patients and as a remedy for post-exercise fatigue. Nevertheless, recent clinical studies have suggested a potential link between D-ribose metabolic disturbances and type 2 diabetes mellitus (T2DM) along with its associated complications. Additionally, certain in vitro experiments have indicated that exogenous D-ribose exposure could trigger apoptosis in specific cell lines. This article comprehensively reviews the current advancements in D-ribose's digestion, absorption, transmembrane transport, intracellular metabolic pathways, impact on cellular behaviour, and elevated levels in diabetes mellitus. It also identifies areas requiring further investigation.

Measurement of CP Violation in B^{0}→ψ(→ℓ^{+}ℓ^{-})K_{S}^{0}(→π^{+}π^{-}) Decays

A measurement of time-dependent CP violation in the decays of B^{0} and B[over ¯]^{0} mesons to the final states J/ψ(→μ^{+}μ^{-})K_{S}^{0}, ψ(2S)(→μ^{+}μ^{-})K_{S}^{0} and J/ψ(→e^{+}e^{-})K_{S}^{0} with K_{S}^{0}→π^{+}π^{-} is presented. The data correspond to an integrated luminosity of 6  fb^{-1} collected at a center-of-mass energy of sqrt[s]=13  TeV with the LHCb detector. The CP-violation parameters are measured to be S_{ψK_{S}^{0}}=0.717±0.013(stat)±0.008(syst) and C_{ψK_{S}^{0}}=0.008±0.012(stat)±0.003(syst). This measurement of S_{ψK_{S}^{0}} represents the most precise single measurement of the CKM angle β to date and is more precise than the current world average. In addition, measurements of the CP-violation parameters of the individual channels are reported and a combination with the LHCb Run 1 measurements is performed.

Switching molecular recognition selectivities by temperature in a diffusion-regulatory porous material

Over the long history of evolution, nature has developed a variety of biological systems with switchable recognition functions, such as the ion transmissibility of biological membranes, which can switch their ion selectivities in response to diverse stimuli. However, developing a method in an artificial host-guest system for switchable recognition of specific guests upon the change of external stimuli is a fundamental challenge in chemistry because the order in the host-guest affinity of a given system hardly varies along with environmental conditions. Herein, we report temperature-responsive recognition of two similar gaseous guests, CO2 and C2H2, with selectivities switched by temperature change by a diffusion-regulatory mechanism, which is realized by a dynamic porous crystal featuring ultrasmall pore apertures with flip-flop locally-motive organic moiety. The dynamic local motion regulates the diffusion process of CO2 and C2H2 and amplifies their rate differences, allowing the crystal to selectively adsorb CO2 at low temperatures and C2H2 at high temperatures with separation factors of 498 (CO2/C2H2) and 181 (C2H2/CO2), respectively.